Polymer-ceramic nancomposites for bone regeneration by Schickert, Sónia de Lacerda
 
 






Dissertação apresentada à Universidade Católica Portuguesa para  



















Dissertação apresentada à Universidade Católica Portuguesa para  





Sónia de Lacerda Schickert 
 

































I owe a sincere and earnest thankfulness, in first place, to my Mentor, Dra. 
Ana Leite Oliveira, for believing in me when I needed the most, helping me 
achieve my professional goals and providing me a prospective future. Her 
example as a professional is one I hope to match someday.  
I would like to thank deeply the department of Biomaterials of the Dentistry 
Faculty at the UMC St. Radboud University, for being so welcoming, so 
supportive and showing an endless availability for helping me whenever I needed. 
A special word of appreciation to Professor Sander Leeuwenburgh, Professor 
Fang Yang, Stefan Remmers and Pedro Babo.  
To all the professors and professionals in the dentistry area that invested 
time in endless explanations, my sincere thank you.  
My word of gratitude to the Portuguese Catholic University, all the 
employees and stuff for the help, support and patience.  
I offer my sincere gratitude to my father, Vítor. The constant support, the 
motivational speeches and endless patience were essential for the conclusion of 
this thesis. His love, affection and understanding way of being makes him my 
number one pillar in life and knowing I can count on him for everything gives me 
courage to face the future.   
A special “thank you” to the Schickerts, especially to Gerhard, who I believe 
helps me from above in all situations (and this dissertation was no exception) and 
tante Christa, for remembering me the value of family and always having a special 
comfort word to offer in the current difficult moments.  
I thank deeply my friends, colleagues and supporters, Maria Inês Barbas, 
Mafalda Barros and Johnny Leite. Without them this study, the 5 years of the 
dentistry degree and life in general would be way more complicated. 
Special thanks to my second family, Rita Mineiro Rodrigues and Filipe 
Rodrigues. In them I found a refugee and an endless support for accomplishing 
this dissertation and my personal and professional goals in life.   
Finally, I would like to thank my mother, for creating the conditions that prove 




Bone is a very important structure in the human body. In the 
craniomaxillofacial complex, trauma and pathological situations such as 
maxillofacial tumors produce major bone defects that cannot be healed by 
physiological processes. As a response to this problem, many strategies have 
been studied throughout the years, with the purpose to find a material that 
reunites ideal properties for regenerating or substituting the needed bone and 
therefore guarantee its physiological and structural functions. Among this 
strategies, transplantation of bone within the same individual (autografts), from 
another human being (allograft) or from an individual of another species 
(xenograft) have been studied and are clinically applied nowadays. However, 
these techniques revealed to have drawbacks such as donor site morbidity, risk 
of disease infection and immunological reactions. In this context, new solutions 
are needed.  
In the field of biomaterials, nanocomposites are considered a promising 
material for many outcomes, mainly because their nanometer-scale allows a 
superior structural performance, when compared to microcomposite materials. In 
the bone regeneration area, ceramic nanocomposites dispersed in a polymeric 
matrix are a promising solution, because they reassemble the physiological bone 
structure, adding unique biocompatible and stimulating properties to the already 
outstanding mechanical behavior.  
The investigation of the different types of ceramic-polymeric 
nanocomposites, as well as the co-factors that can be added to enhance the 
biological response and their processing ability for the commercial level, is 
extremely relevant. This study intends to present a review of the published 
information about the in vivo and in vitro studies that have been performed in the 
last 5 years and their contribution for the development of an ideal nanocomposite 
material to be used in bone regeneration, particularly in the craniomaxillofacial 
context.  




 O osso é uma estrutura muito importante no corpo humano. No complexo 
crâniomaxillofacial, situações como trauma e tumores maxillofaciais têm como 
resultado defeitos ósseos de grandes proporções que não são passíveis de ser 
curados por processos fisiológicos. Com o intuito de dar resposta a este 
problema, várias estratégias têm vindo a ser estudadas ao longo do tempo, para 
encontrar um material que reúna as propriedades ideias para a regeneração ou 
substituição do osso em défice e assim garantir o restabelecimento as suas 
funções fisiológicas e estruturais. De entre estas estratégias, a transplantação 
de osso no mesmo indivíduo (autotransplante), transplantação de osso entre 
seres humanos (alotransplante) e de osso de indivíduos de outra espécie 
(xenotransplante) têm sido estudadas e são clinicamente utilizadas hoje em dia. 
Contudo, estas técnicas têm mostrado possuir alguns inconvenientes como são 
a morbilidade da zona óssea dadora, risco de doença infeciosa e reações 
imunológicas. Neste contexto, novas soluções são necessárias.  
 Na área de biomateriais, os nanocompósitos são considerados um 
material promissor para vários fins, principalmente porque a sua escala 
nanométrica permite uma performance estrutural superior, quando comparada 
com materiais microscópicos. Em regeneração óssea, nanocompósitos 
cerâmicos dispersos numa matriz polimérica, apresentam-se como uma solução 
promissora, uma vez que simulam a estrutura fisiológica do osso, adicionando 
propriedades de biocompatibilidade e estimulação únicas ao já muito bom 
desempenho mecânico.  
 A investigação de diferentes tipos de nanocompósitos cerâmico-
poliméricos e cofatores que possam ser adicionados para melhorar a resposta 
biológica, bem como técnicas de produção para uma possível escala comercial, 
é extremamente relevante. Este estudo tem como objetivo apresentar uma 
revisão da informação publicada sobre estudos in vivo e in vitro que têm sido 
efetuados nos últimos 5 anos e o seu contributo para o desenvolvimento de um 
material ideal. 
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Natural bone has a great healing capacity. Through times, this capacity has 
been studied in order to understand what the limitations are and how they could 
overcome. A well-known limitation of the natural healing process is related to the 
extension of the bone defect. When the lesion is larger than 2 mm, the bone 
structure is not capable of regenerating by itself.1 Situations such as diseases, 
abnormalities or trauma which have as a consequence major bone defects have 
been extensively studied in order to find the best therapeutic solutions.2 
In the craniomaxillofacial skeleton, bone defects can vary from small (few 
millimeters) periodontal defects, to large segmental defects that are originated 
mainly in major trauma, followed by surgical excision or cranioplasty.3 Such 
structures, have a complex tree-dimensional structural need, which is difficult to 
fulfill. In cranial vault defects, the underlying brain needs permanent protection. 
Segmental jaw defects require restoration of mechanical integrity, 
temporomandibular joint function and inter-maxillary dental occlusion. 
Maintaining acceptable facial esthetics is another unique consideration in the 
treatment of facial defects that cannot be underestimated.3   
Due to the constant need to heal, techniques to replace, restore, or 
regenerate bone were noticed as a major clinical quest in the fields of orthopedic, 
spinal, dental, cranial and maxillofacial surgery. The earliest report of a bone 
grafting procedure appeared in 1682, in a book by Job Janszoo van Meekeren, 
a surgeon in Amsterdam. In this document, the author reported a case in Russia, 
where the surgeon restored a cranial defect using a cranial bone graft from a 
dead dog.4 In 1881, Sir William MacEwen of Rothesay, from Scotland, published 
the first case report of successful inter-human transfer of bone grafts.5 Since then, 
many changes occurred due to centuries of subsequent research both in 
academia and industry.  
Now-a-days new materials are being investigated, with the purpose of 
changing the goal of bone grafts from just a replacing role, to the complete bone 
restauration, allowing for the own bone to grow and regenerate itself. In this 
context, polymer-ceramic nanocomposites arise as important candidates for this 
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application, since bone itself is composed by polymer-ceramic nanocomposite 
structure.  
 
1. The Bone Biology  
 
Bone is a calcified, living, connective tissue that forms the majority of the 
skeleton. Their basic constitution is an intercellular calcified matrix, containing 
collagen fibers and several types of cells within the matrix.6 Actually, bone is the 
only mineralized (collagen mineralized with calcium phosphate) structure that 
contains living cell bodies on its structure. Dentin, for example, is composed of 
collagen mineralized with calcium phosphate but it does not contain cell bodies, 
only tubular extensions of cells.7 Other significant tissue mineralized with calcium 
phosphate is the enamel.7 However, in this case, there are virtually no cells or 
cell processes or, indeed, much too organic matrix.  
There are two major types of bone: Cancellous (also called spongy bone) 
and Cortical.8 Cancellous bone forms the internal pours framework of bones. It 
contains stem-cells-rich bone marrow which is essential for the growth of new 
connective tissue (e.g. muscle, cartilage, bone and tendons) and the production 
of blood cells. Cortical bone surrounds the cancellous bone and forms an outer 
shell, thus giving the bone shape and form. In load bearing bones, the cortical 
component is markedly thickened to form a strong shaft. 
Bone is responsible for 5 basic functions:6 (a) to support all the body 
structures, (b) to protect vital organs, (c) to be a reservoir of calcium and 
phosphorus, (d) to function as a lever on which muscles act to produce movement 
and (d) to host blood-producing cells.  
In terms of development, all bones are originated in the mesenchyme either 
by intramembranous ossification, in which mesenchymal models of bone undergo 
ossification or endochondral ossification, in which cartilaginous models of bones 
form and undergo ossification.6 There are five distinct types of cells associated 
with bone tissue formation and regulation: osteoprogenitor cells, osteoblasts, 
osteocytes, osteoclasts, and bone-lining cells.9 Osteoprogenitor cells (or bone 
precursor cells) have the ability to proliferate and differentiate into bone cells. 
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Osteoblasts are the cells that are responsible for the formation of new bone 
tissue. They start with secreting collagen followed by coating non-collagenous 
proteins, which are similar to a glue that has the ability to bind the minerals, mostly 
calcium and phosphate, from the bloodstream. Osteocytes are matured cells 
derived from the osteoblasts that are responsible for the maintenance of the bone 
tissue. They function as transporting agents of minerals between bone and blood. 
Osteoclasts are the largest cells found at the surface of bone mineral. They are 
responsible for the resorption of the bone tissue. They secrete acids or enzymes 
to dissolve the minerals as well as collagen from the matured bone. The dissolved 
minerals then re-enter the bloodstream and are carried to different parts of the 
body. Bone-lining cells are found along the surface of the matured bone and are 
responsible for regulating the transportation of minerals in and out of the bone 
tissue. They also respond to hormones by producing proteins that activate the 
osteoclasts. Together, these five types of cells are responsible for building the 
bone matrix with hierarchical structure, self-assembly ability and remodeling 
capability. All these processes must be in equilibrium to ensure a healthy bone 
tissue.6-9 
When bone suffers an injury, it possesses natural healing capacity which 
allows for a successful regeneration. After damage, the bone adjacent structures 
cause a hematoma around the broken bone ends.10 Fibroblasts enter the site and 
form granulation tissue, composed predominantly of type-III collagen.  Then, two 
different processes occur in the proximal and the distal site. In the proximal, 
chondroblasts arise from the periosteum and produce hyaline cartilage. In the 
distal site, osteoblasts arise from the periosteum and produce woven bone 
(majorly constituted by type-I collagen).10 Both sites combine and form the 
fracture callus. The woven bone then undergoes substitution and the hyaline 
cartilage undergoes endochondral ossification. These processes both produce 
lamellar bone. Osteoblasts and vascular channels penetrate the mineralized 
matrix and stronger trabecular bone is laid down. From here, final remodeling 
occurs by the deposition of compact bone by osteoblasts in resorption pits 
prepared by osteoclasts.10 This process, known as primary or direct osteonal 
healing, is just possible if the gap between bone ends is less than 2 mm and 
absolute stability exists.  
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1.1. Craniomaxillofacial anatomy and physiology  
 
 The skull is divided in two major parts: The neurocranium and the 
viscerocranium.11 The neurocranium, constituted by the cranial bones form the 
cranial cavity which encloses and protects the brain. In addition, the cranial bones 
stabilize the positions of the brain, blood vessels, lymphatic vessels and nerves 
through the attachment of their inner surfaces to meninges (membranes). The 
outer surface of cranial bones provide large areas of attachment for muscles that 
move various parts of the head. Underneath it, the skull base forms the floor of 
the cranial cavity and separates the brain from other facial structures.11,12 
Anteriorly attached to the skull is the viscerocranium.  
 The viscerocranium forms the anterior part of the cranium and consists of 
facial bones surrounding the mouth, nose, and most of the orbits. They consist 
on the framework for the face and provide support for the entrances to the 
digestive and respiratory systems.  Therefore, vital functions such as breathing, 
eating, talking, smelling, seeing and having equilibrium are ensured by this 
bones. Moreover, it is also an esthetically important region. Therefore, any 
change to its normal constitution and/or function seriously damages the 
individual’s life quality.12 In such situations, maxillofacial surgery applies different 
technics for healing and restoring the normal function.  
 
1.2. The need for maxillofacial surgery  
 
Surgeries concerning the use of bone replacements or bone grafts in the 
craniomaxillofacial area are requested in two major situations: in case of trauma 
or when there is a pathological abnormality in the anatomy and physiology of this 
area (e.g. a congenital and developmental deformity or an acquired condition).  
Causes of craniomaxilofacial trauma injuries vary from interpersonal 
violence to rodoviary accidents.13 Fractures of the maxilla are the result of 
considerable force and are often associated with craniocerebral injury. The 
maxilla offers a high resistance against forces directed upwards but relatively little 
resistance if the impact is directed horizontally. Fractures may occur at three 
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levels, Le Fort I, II and III, and may be unilateral or bilateral (Figure 1-A). The palate 
may also be fractured in the midline. Mandibular fractures, which are the ones 
that happen more often,11,13-15 may happen in different sites of the mandible 
(Figure 1-B). The symptoms and signs of a fractured mandible include pain and 




Congenital and developmental deformities of the cranial skeleton occur due 
to errors in the growth process while the fetus is in utero and tend to become 
more evident in the pubertal growth spurt.15 They have the particularity of being 
really easy to diagnose, since the facial deformity is obvious, but extremely 
difficult to categorize. Since the skin drapes over the bony skeleton, most 
deformities are caused by bone abnormalities (soft tissue abnormalities are rare 
and when they occur, they are commonly secondary to skeletal abnormalities). 
According to Booth et al.,15 these abnormalities can be broadly subdivided into 
craniofacial anomalies, clefting anomalies and orthognathic deformities. This last 
one involves the dentofacial anomalies that can be corrected by orthognathic 
surgery, repositioning parts of the facial skeleton to correct the deformity. 
Craniofacial and clefting anomalies, may require bone grafts to add bone tissue 
or realign it through complex maxillofacial surgeries.  
Figure 1 – Maxillofacial Trauma 
(A) Mandibular Fractures: Le Fort fracture I, II and III. (B) Incidence of fractures 
occurring at various sites of the mandible. 15 
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 In the craniomaxillofacial complex, a high percentage of diseases affecting 
the bones are tumoral conditions.16 Bone tumors of the maxillofacial region may 
arise from osteogenic, chondrogenic, fibrogenic, vascular, hematopoietic and 
other elements of the bone.17 Table 1 shows the World Health Organization 
classification of benign and malignant bone tumors of the maxillofacial region.18 
As a consequence to tumors excisions, a critical-sized bone defect remains, 
leading to noticeable deformity and dysfunction. These situations generally 
require reconstructing strategies such as the replacement with autogeneous or 
allogenic bone grafts, xenografts or alloplastic materials. The clinical results of 
these procedures are limited, since the craniomaxillofacial bones have a complex 
three dimensional structure and the replacement materials do not possess the 
necessary characteristics to fulfill their goal.19 Other request for bone 
augmentation has to do with the loss of alveolar bone after teeth loss. The main 
purpose of creating new alveolar bone is generate a bone structure to anchor 
dental implants and dentures and allow the requalification of the orthognathic 
system.19 
 
Table 1 - World Health Organization classification of benign and malignant bone 
tumors of the maxillofacial region 18 
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1.3. Bone as a Nanocomposite 
 
 Nanocomposites are defined as a heterogeneous combination of two or 
more materials in which at least one is at the nanometer-scale.20 A good example 
of a nanocomposite is bone tissue: it is composed of two major phases at the 
nanoscale level, namely the organic (protein) and the inorganic (mineral).  These 
phases have multiple components which consist of, in decreasing proportions: 
minerals, collagen, water, non-collagenous proteins, lipids, vascular elements, 
and cells (Table 2).21 The mineral of bone is mainly composed of HA and the 
organic part of bone is mainly composed of collagen. Here, collagen acts as a 
structural framework in which plate-like tiny crystals of HA are embedded to 
strengthen the bone. Bone collagen has a typical fibrous structure, whose 
diameter varies from 100 to 2000 nm. Similarly, HA in the bone mineral is in the 
form of nanocrystals, with dimensions of about 4nm by 50nm by 50nm.22,23 The 
primary role of minerals is to provide toughness and rigidity to the bone, whereas 
collagen provides tensile strength and flexibility needed.21 In other words, the 
function of collagen fibers is to provide strength in tension and resistance in 
bending whereas the apatite crystals embedded between the nanofibers will 
resist to compression.24 
 
Table 2 - Components of bone 21,23 
(This composition can vary slightly from species to species and from bone to bone) 
 
Inorganic Phase Wt % Organic Phase Wt % 
Hydroxyapatite ≈ 60 Collagen ≈ 20 
Carbonate ≈ 4 Water ≈ 9 
Citrate ≈ 0,9 Non-collagenous proteins 
(osteocalcin, osteonectin, 
oeteopontin, thrombospondin, 
morphogenic proteins, sialoprotein, 
serum proteins) 
≈ 3 
Sodium ≈ 0,7 
Magnesium ≈ 0,5 
Other traces (Cl- , F- , K+ , Sr 2+, Pb 2+,  
Zn 2+, Cu 2+, Fe 2+) 
Other traces 
(Polysaccharides, lipids, cytokines) 
Primary bone cells 
(Osteoblasts, osteocytes, osteoclasts) 
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1.4. Hierarchical structure 
 
 Because of its structural function, bone needs to be tough and resistant. 
The key to this strength is the complex structural hierarchy into which it is 
organized in a self-assembling mode. Thus, bone can be considered as an 
assemblage of various levels of hierarchical structural units elegantly designed 














At the macrostructure level, matured bone can be divided in two types: 
spongy bone and compact bone. Structurally they are different because they play 
different roles in bone. Spongy bone represents approximately 20% of the total 
amount of bone, whereas compact bone represents the other 80%. Spongy bone 
is very porous and light and has a high concentration of blood vessels (which are 
Figure 2 - Bone hierarchical organization  
(a) the macrosctructured level: bone is divided in compact and spongy bone; (b) the microstructured 
level: osteons; (c) and (d) the mesostructured level: lamellae and its fibrillar composition (e) the nanoscopic 
level:  the 2 major components, collagen and HA. 2,8 
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responsible for the transportation of nutrients, oxygen and body fluids). Compact 
bone, on the other hand, has a very dense structure and is less porous, not being 
able to host a large amount of blood vessels. The compact bone functions include 
supporting bone mechanically in tension, compression and torsion. Spongy bone 
functions mainly in compression.8 
 At the microstructural level, compact and spongy bone have different 
structural units. In compact bone, osteons or harvesian systems repeat 
themselves working as weight-bearing pillars, while spongy bone contains an 
interconnecting framework or trabeculae.8 Each osteons consists of concentric 
layers, or lamellae, that surround a central canal, the haversian canal, that 
contains nerve and blood supplies. As the body ages, the number of osteons 
increase, resulting in a tissue completely filled with osteons, which are in direct 
contact with each other. When bone is compressed, osteons present a unique 
crack pattern, consisting of stacks of ark-shaped circumferential microcracks that 
propagate radially from the center of each osteon.8 As the compression level 
rises, the radial cracks that exist in the neighboring osteons connect, forming a 
network of cracks throughout the tissue that redistributes the stress and 
preventing the catastrophic failure, despite the large amount of energy applied. 
Furthermore, this unique type of microcracking allows the material to maintain its 
high strength and resilience even in the inelastic regime of deformation. This 
example illustrates how the hierarchical organization of bone (in this case in the 
microstructural level) determines its unique mechanical resilience.8 
 The lamellae are made of one or more parallel fibrillar arrays varying in 
thickness from a few hundred nanometer to a few microns. The thicknesses and 
the main fibril direction in neighboring lamellae can vary leading to the formation 
of unique patterns that are often species specific and can even vary among 
different bone types in the same species. The spaces between the fibrils contain 
extrafibrillar mineral crystallites and noncollagenous molecules, such as 
glycoproteins and glycosaminoglycans that provide a viscoelastic medium 
isolating the collagen fibrils. In addition, this non-collagenous proteins have other 
important function: they form a supramolecular network based on the ionic cross-
links between their acidic side chains and the calcium ions in the solution as well 
as the interactions between these acidic moieties and calcium ions on the surface 
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of mineral crystal. This ions based, reversible and sacrificial networks dissipate 
large amounts of energy under mechanical stress and reforms quickly when the 
load is off.8,23,25 In the hierarchical structure, the mesostructural level is of 
particular importance because although its basic components are in the 
nanoscopic level, the chains that they form together have specific mechanical 
functions when joined. This can be considered as another good example of the 
benefits of bone’s hierarchical organization.  
 Finally, at the nanostructured level, the two major components (collagen 
fibers and nanocrystals of HA) are found (Figure 3) in higher proportions among 
other minor components such as non-collagenous proteins, molecules of water 
and lipids. The presence of water and lipids is essential for cellular functions: 
water plays and important role in fluid movement within bone, transports nutrients 
and waste products and also calcium and cytokine factors, and is an important 
determinant of the biomechanical behavior of bone while lipids play an important 















The nanoscopic detail of a fibril 26 
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Structurally, a collagen framework embeds plate-like tiny crystals of HA. 
This conformation is essential because the mechanical properties that are 
characteristic of the bone tissue exist do to the isolated and combined properties 
of its nano components. This means that, in the end, all boils down to high level 
of integration of the mineral and organic phases at atomic and molecular levels.7 
A badly formed collagen has compromising effects on the structural and 
mechanical characteristic of bone and an example of this is Osteogenis 
Imperfecta. In this disease, a mutation in the genes that are responsible for the 
production of collagen type I can lead to an abnormal triple helix structure, 
compromising the whole bone structure.27 Moreover, Currey et al., 28 preconized 
that one of the reasons why ionized radiation decreases the bending strength and 
the work to fracture of bone structures, is due to the radiation specific damaging 
of the collagen matrix in an irreversible way.  
Nonstoichiometric carbonated hydroxyapatite is the specific type of HA 
found in bone tissues. The fact that it presents itself in plate-like crystallites with 
very small average dimensions is the reason for the unique mechanical behavior 
of its structure. In fact, Gao et al.29 demonstrated that crystals this small are 
extremely tolerant to flaws and that this hydroxyapatite specific crystals have a 
strength of a perfect crystal. Other favorable characteristic is the high surface and 
bulk ratio of these crystallites that increase their chemical reactivity and 
consequently the interactions with the organic molecular components.30 
 
2. Bone Grafts  
 
Bone grafting is a surgical procedure which entails replacement or 
reconstruction of missing or damaged  bone with material from either patient's 
own body, an artificial or natural substitute.31 In order to accomplish its goal, bone 
grafts should be osteoconductive, osteoinductive and osteogenetic:32 (A) 
Osteoconduction is a term that means that bone grows on a surface. Therefore, 
an osteoconductive surface is the one that has ideal characteristics to permit 
bone growth, by stimulating the attachment, survival, migration and distribution 
of cells that are involved in bone formation such as mesenchymal cells, 
osteoblasts, osteoclasts, and vasculature; (B) Osteoinduction refers to the 
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process in which primitive, undifferentiated and pluripotent cells are somehow 
stimulated to develop into a bone forming cell lineage. It can be considered that 
osteoinduction is the process by which osteogenesis is induced; (C) 
Osteogenesis is the formation of bone in general. It can be produced by cells of 
the host or by living cells included in the graft.33,34 
 
2.1. Classification of Bone Grafts  
 
There are several categories of bone grafts which encompass a variety of 
materials, material sources, and origins.33 In order to present a more complete 
classification, one will be used, adapted from Laurencin et al..35 
 




Allografts constitute 58% of the bone substitutes and are typically tissues 
harvested from the patient’s own bone tissue such as the iliac crest.2 They are 
considered the gold standard for bone repair, because they offer minimum 
immunological rejection, complete histocompatibility and provide the best 
osteoconductive, osteogenic and osteoinductive properties. Autografts usually 
contain viable osteogenic cells, bone matrix proteins and support bone growth 
which are obtained from vascularized and non-vascularized cortical and 
autologous bone marrow grafts. They offer structural support to implanted 
devices and ultimately become mechanically efficient structures as they are 
incorporated into surrounding bone through creeping substitution.33 However, 
they are limited in availability and often associated with donor-site morbidity and 




Allografts are tissues obtained from banked freeze-dried bones of human 
cadavers and represent about ≈34% of the bone substitutes. They are 
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osteoconductive and have fewer limitations on supply.35 However, allografts are 
usually not osteoinductive or osteogenic and are associated with risks of 
immunological reaction or disease transmission. Furthermore they possess 




Xenografts are harvested from one individual and transplanted into another 
individual of a different species. The common available xenografts are derived 
from coral, porcine, and bovine sources.37 Xenogenous bone grafts are a 
theoretically unlimited supply of available material if they could be processed to 
be safe for transplantation in humans. A major concern with bovine-derived 
products is the potential transmission of zoonotic diseases and prion infections 
such as bovine spongiform encephalitis (BSE). Xenografts, similar to allograft, 
lose their osteogenic and partly osteoinductive properties during the processing 
to counteract their antigenic properties and prevent transmission of infection.38 
Because xenografts produce poor clinical outcome, new insights in this same 
field have been investigated. For example, Keskin et al.,39 evaluated the 
effectiveness of autologous bone marrow on the healing of bone defects filled 
with bovine-derived xenografts in rabbits. They concluded that when xenografts 
were combined with autogenous red bone marrow, the drawbacks of xenografts 
are slightly compensated, but even with this enhancement of biocompatibility, 
their origin and properties continue to arise unsolvable problems.  
 
b) Bone Graft Substitutes 
 
While harvested bone grafts use pre-existing bone, bone graft substitutes 
are biomaterials made of a variety of sources and using different strategies to 





Growth factor-based bone graft substitutes 
 
Growth factors are secreted by a wide range of cell types to transmit signals 
that activate specific developmental programs, controlling cell migration, 
differentiation and proliferation.40 Therefore, integrating them in a biomaterial with 
regeneration purposes is a great strategy for enhancing its biological properties, 
simulating host cells to adhere to the material and proliferate. Polymeric systems 
can be successfully used to administer small doses of factors at defined dose 
rates directly to target cells. In fact, biodegradable polymers are able to provide 
a controlled release of growth factor delivery through its degradation rate. In the 
bone regeneration field, osteoinductive growth factors have been reported.41,42  






Table 3 - Influence of growth factors on graft incorporation and bone healing.43 








osteoblasts and chondrocytes 
Increases cell replication 















growth factor β 
Platelets, osteoblasts and 
chondrocytes 
Increases proteoglycan 




-2, -4, -7. 
Mesenchymal stem cells, 
osteoblasts 
Induces progenitor cells to 
become bone-forming cells. 
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Among this group of growth factors, BMPs are a group of high interest. They 
are members of the β-transforming growth factors (β-TGF) superfamily and have 
been identified as having different degrees of cellular activity, including cartilage 
or bone inducing properties. Lee et al., 41 demonstrated that the use of BMP-2 
enhanced significantly bone regeneration in a critical size femoral defect rat 
model in amounts that are one order of magnitude lower than that required for 
healing in this animal. The presence of more mature bone in the new ossified 
tissue was noted when a low dose of BMP-2 was delivered using a biomimetic 
supramolecular system. In human patients, the failure to naturally regenerate 
bone seems to be related to the genetic changes in the BMP signaling system.44 
The US Food and Drug Administration (FDA) has approved two recombinant 
proteins that are presently commercially available: recombinant human bone 
morphogenic proteins rhBMP-2 and rhBMP-7.31 Clinical orthopedic studies have 
shown the benefits of these recombinant human BMPs but side effects such as 
swelling, seroma, and increased cancer risk, have been reported, probably due 
to high BMP dosage.42 
 
Cell-based bone graft substitutes 
 
These bone grafts combine living cells with biomaterial scaffolds ex vivo to 
allow the development of a three-dimensional structure. Autologous cells may be 
used in this approach via the isolation of a small number of differentiated adult 
cells or stem cells, followed by in vitro expansion to produce the material that will 
be reimplanted in the host posteriorly.40 Mesenchymal stem cells (MSC) are 
capable of continuously replicate themselves, while a portion becomes 
committed to mesenchymal cell lineages such as bone, cartilage, tendon, 
ligament, and muscle, depending on the outer stimuli that they receive. They are 
considered to be a great tool for regenerative cell therapy and have been used 
since the 1980s, when Friedenstein et al.45 first reported their effectiveness on 
developing engineered tissues.   
Wong et al.,46 in a clinical trial performed with injectable cultured bone 
marrow-derived mesenchymal stem cells was able to regenerate cartilaginous 
and osseous tissues in patients that suffered a high tibial osteotomy procedure. 
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Though this study, the authors proved the effectiveness of the mesenchymal cell 
based treatments.  
Osteocel ® Plus, a commercially available example of cell-based bone graft 
is produced by NuVasive ® since 2005. It consists in an allograft cellular bone 
matrix containing mesenchymal stem cells (MSCs) and osteoprogenitor cells 
extracted from adult donor tissues, combined with Demineralized bone matrix 
(DBM) and cancellous bone.  
 
Ceramic-based bone graft substitutes 
 
These bone grafts have in its constitution ceramic based materials, such as 
calcium phosphate, calcium sulfate, and bioglass used alone or in combination. 
Bioceramics can be divided in 4 categories: they can be silicate-based, as are 
wollastonite (CaSiO3), bioglasses and diopside (Ca2MgSi2O6), phosphate-based, 
as are hydroxyapatite and β-TCP, carbonate-based, as are the coral-ceramic 
(CaCO3) and finally sulfate-based, as is calcium-sulfate (CaSO4). The major 
component of these ceramics determines its biological behavior towards natural 
bone.  
OsteoGraf ® (DENTSPLY ®) and Osteoset ® (Wright Medical Technology 
®) are two commercial examples of these materials. The first, Osteograft ®, uses 
hydroxyapatite as bone graft material in either a block or a particulate form, 
whereas Osteoset ® is a calcium sulfate tablet used for bone defect sites.  
 
Polymer-based bone graft substitutes 
 
These are bone grafts that use natural or synthetic, degradable or non-
degradable polymers alone or in combination with other materials.  Some 
commercially available examples include CORTOSS ® (Orthovita ®), which is a 
self-setting glass ceramic polymeric composite engineered specifically to mimic 
the characteristics of human bone and to provide fixation for vertebral 
compression fractures, among others.  
 
19 
2.2. Essential properties of bone grafts 
 
The biological process leading to graft incorporation is very similar to that of 
fracture repair.3 Bauer et al. 47 summarized graft incorporation into five major 
steps:  
I. Hematoma formation, release of bone inducing factors and cellular 
recruitment; 
II. Inflammation and development of fibrovascular tissue, connecting the 
graft to the adjacent bone 
III. Vascular invasion of the graft; 
IV. Focal resorption of the graft by recruited osteoclasts; 
V. New bone formation, union between the graft and the surrounding bone, 
and graft remodeling. 
In order to accomplish the incorporation stages properly, the bone graft has 
to have some basic characteristics. The primary requirements of any implant 
material or device are related to their biocompatibility aspects and in vivo 
function3,31,32,35,47. First of all, bone grafts should be biocompatible so that they 
can integrate with the host tissue without any harmful immune response.48 In 
order to enhance this property, modified implant surfaces may regulate the host 
response, attachment of cells and their functions.49 Furthermore, bone 
regeneration strategies should be biodegradable with non-toxic degradation 
products that can be metabolized and excreted by the body, and with controllable 
degradation kinetics to match the rate of bone healing process so that the newly 
formed tissue compensates the mechanical and mass loss of the degraded 
matrices. Products that may result from corrosion, resorption, hydrolysis and 
enzymatic reactions, may direct local and systemic immune responses, affecting 
significantly the implant-host integration.50  
A complete regeneration and functional restoration may be achieved when 
the bone graft is well integrated with the host, remodeled and replaced with native 
bone tissue. To ensure this process, the material should have a porous structure 
to enable the transport of oxygen and nutrients.51 Porosity is the percentage of 
void space within a solid object.33,51 Although it is known that the ideal pore size 
for a synthetic bone graft, should be similar to that of spongy bone,33 there is not 
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a consensus among researchers about its ideal size. It has been demonstrated 
that microporosity (pore size <10 μm) allows body fluid circulation whereas 
macroporosity (pore size >50 μm) provides scaffold (pore size-100-200 μm and 
porosity-60-65%) for bone-cell colonization.52 For instances, Gauthier et al.53 
reported that the ideal macropore size for bone ingrowth is a pore size diameter 
of ~600 μm, because it provides better biological responses when compared to 
a smaller size (~300 μm) whereas Kuhne et al.54  demonstrated in an in vivo study 
performed in rabbits that the optimal size of the pores in a coralline hydroxyapatite 
bone substitute is ~500 μm. Besides porosity, surface roughness is also very 
important, since it promotes cellular adhesion, proliferation, and differentiation of 
anchorage-dependent cells.51 
A bone graft substitute should have adequate mechanical properties to 
support the native forces usually experienced under loading.19 This is most critical 
to protect the tissues and transmit the compressive and tensile force and 
mechanical cues across the defect to the regenerative cells. The degradation 
profile of the implanted graft should allow the mechanical load to be supported 
and gradually transferred to the newly forming tissue within the implant.55  
To enhance the cell infiltration and consequently the regeneration of new 
bone tissue, osteoconductive materials such as hydroxyapatite, collagen, 
autogenic and allogenic bone can be used.1 Other effective solution can be the 
use of osteoinductive materials, such as demineralized bone matrix (DBM). 
Kinard et al. 56 stands that DBM promotes formation of new bone when applied 
to defect sites. That has to do with the fact that DBM possesses in its constitution 
BMPs, which, as already referred, are proteins with a huge osteoinductive 
capability. By using DBM in a biodegradable hydrogel, the authors were able to 
promote bone augmentation in rats, correlating directly the DBM dose with the 
amount of new-formed bone. Other osteoinductive responses may be produced 
by several growth factors, as referred before, always concerning the best host-




3. Matching bone through nanocomposites  
 
In order to replace the classical solutions to bone replacement, several 
approaches have been studied throughout the years. Therefore, and regarding 
the nanostructure of bone with its organic (collagen) and inorganic (HA) phase, 
research has been conducted to develop therapeutic materials with the same 
hybrid structure that combine the strength, stiffness and osteoconductivity of an 
inorganic component with the flexibility, toughness and resorbability of an organic 
phase. In this context, researchers have developed polymer-ceramic 
nanocomposites which have the advantages of both polymers (structural stability, 
strength, biocompatibility and desired shape) and ceramics (bioactivity and 
osteoconductivity), and are more close to natural bone.1,57  
Polymers have been used (combined or individually) in different applications 
(Figure 4).58 They can be divided into two groups regarding their source: natural 
and synthetic. Cellulose, collagen, agarose, chitin or hyaluronan form the 
members of natural polymeric materials or so-called biological polymers.31 
Natural polymers such as collagen have been used for bone tissue engineering 
purposes. In contrast to natural polymers, synthetic polymers are also used in the 
bone engineering field. Some examples of these polymers are poly-lactic acid 
(PLA), poly-glycolic acid (PGA), polyurethane (PU) and polycaprolactone (PCL), 
from which PLA and PLGA have receives the highest interest because of their 
















Regarding their response when applied to living tissues, polymers can be 
biodegradable or non-biodegradable. Biodegradable synthetic polymers, like 
natural polymers, are resorbed by the body. To have the implant being resorbed 
by the body while the replacing tissue is regenerating is highly advantageous. 
Figure 4 - Various applications of composite - polymers throughout the body 58 
Legenda 
CF: Carbon Fibers; C: Carbon; GF: Glass Fibers; KF: Kevelar Fibers; PMMA: Polymethylmethacrylate; PS: Polysuifone; 
PP: Polypropylene; UHMWPE: Ultra-high-molecular weight polyethylene; PLDLA: poly (L-DL- Lactide); PGA: 
Poliglycolic acid;  PC: Polycarbonate; PEEK: Polyethereutherketone; HA: Hydroxyapatite; PMA: polymethacrylate; BIS-
GMA: Bis-phenol A glycidyl methacrylate; PU: polyurethane; PTFE: Polytetrafluorethylene; PET: Polyetylenetephthale; 
PEA: Politethylacrylate; SR: Silicone rubber; PHB: Polyhydroxybutyrate; PEG: Polyethyleneglycol; PHEMA: Poly 
(20hydroxyethyl methacrylate) 
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These polymers do not require a second surgical event for its removal once it is 
no longer needed. This last characteristic can be a huge advantage in the bone 
field, because the bone can develop a phenomenon called “stress shielding”: 
when a bone fractures and it is fixed with a rigid, non-biodegradable stainless 
steel implant, it may not heal properly and can eventually re-fracture upon 
removal of the implant.59 Bone does not carry sufficient load during the healing 
process, since this is carried mostly by the rigid stainless steel.59 However, an 
implant prepared from a biodegradable polymer can be engineered to degrade at 
a rate that will allow for the slow transfer of the load to the healing bone.60 
Poly(glycolic acid), poly(lactic acid) (PLA) and their copolymer poly(lactide-co-
glycolide) (PLGA), polydioxanone, poly (ethylene oxide) and poly(trimethylene 
carbonate)  are examples of polymers that have been used for this purpose. In 
addition, poly(ε-caprolactone) (PCL), polyanhydrides, poly(vinyl alcohol) (PVA), 
polyurethanes and recently polyhydroxykanoates (PHA) which are linear 
polyesters of microbiological origin, have also been investigated for bone 
regeneration.31,57   
At the same time, non-biodegradable polymers have been used in bone 
tissue engineering due to their better mechanical properties and chemical stability 
than biodegradable polymers.57 In the bone field, these materials are mainly used 
when the tissue cannot be regenerated due to large losses or for elderly patients 
with a less effective self-healing ability of the tissue. Currently, synthetic 
nonbiodegradable polymers used are for instances: polyethylene, polypropylene, 
polytetrafluoroethylene, poly (vinyl chloride), polyamide (PA), poly (methyl 
methacrylate), polycarbonate, poly (ethylene terephtalate), poly (ether ketone), 
acrylics and silicones.57 
 Ceramics such as calcium phosphates and calcium sulfates are clinically 
used as implant coatings or bone-void fillers because of their attractive 
biodegradable, bioactive and osteoconductive properties, and also because they 
have a notable ability to bond directly to bone.57 Calcium phosphates appear in 
several different forms, being hydroxyapatite (Ca10(PO4)6OH2) and tricalcium 
phosphate (Ca3(PO4)2) the most currently used.1 Hydroxyapatite (HA) is a 
naturally occurring calcium phosphate that comprises up to 70% of the dry weight 
of bone. The synthetic form of HA is osteoconductive and can have a crystalline 
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structure similar to the HA in bone. HA synthesized at high temperatures is highly 
stable and slower to resorb than its endogenous form and may stay at the site of 
implantation for many years. Tricalcium phosphate (TCP) is a bioceramic that 
exists in alpha (α-TCP) and beta cristal (β-TCP) forms.61 α-TCP is the high-
temperature and β-TCP is the low-temperature polymorph of TCP.62  
β-Tricalcium phosphate (β-TCP) has been successfully used in 
posterolateral spinal fusions, dental procedures and as a component of bio-
resorbable screws.63 In fact, Ogose et al. 63 demonstrated that β-TCP appears to 
be advantageous in comparison to HA for surgery involving bone tumors and 
exibits superior osteoconductivity. Calcium sulphate (CaSO4) is resorbed within 
6 weeks – which is faster than both HA and TCP. It was already successfully 
used in tuberculosis. Calcium sulphate pellets have been used as autograft 
extender for instrumented short segment posterolateral spinal fusions for 
degenerative disease.64  Although the biological characteristics are favorable for 
bone engineering purposes, the main drawbacks of these materials are their 
brittleness, low fracture strength, low mechanical reliability, lack of resilience and 
high density which makes them susceptible to catastrophic failure. 
 
3.1. The structural organization of polymer-ceramic 
nanocomposites 
 
Typically, the polymer-ceramic composites used for bone replacement and 
regeneration are systems in which a ceramic filler is dispersed within a polymer 
matrix. In nanocomposites, the dispersed filler material is at the nano dimension. 
One of the main reasons for using nanomaterials is the large surface to volume 
ratio, which increases the number of particle-matrix interactions, increasing the 
effects on the overall material properties.65,66 The interphase formed around 
nanoparticles exhibits distinct properties from those of the bulk matrix.67 It can be 
a region of altered chemistry, polymer chain mobility, degree of cure or 
crystallinity Therefore, by controlling the degree of interaction between the 
polymer and the nanofiller, the properties of the entire matrix can be controlled.68   
Another important consideration is the dispersion of the filler,65 since a well 
dispersed system yields more desirable composite properties. For instance, 
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particle agglomerates decrease the material performance by the inclusion of 
voids that act as preferential sites for crack initiation and failure.65 Particles, 
especially in the nano range (less than 100 nm) tend to agglomerate, or cluster, 
due to the dominant intermolecular van der Waals interactions between them.65 
Therefore, when fabricating a polymer-nanocomposite scaffold, the technique to 
disperse nanoparticles into the polymer matrix is important, because it provides 
a good mechanical behaviour in vivo.  
In order to simplify the discussion about nanofillers, Ajayan et al.68 grouped 
nanofillers into three categories, according to their geometrical shape: fiber-like, 
plate-like and three-dimensional (Figure 5). This is a convenient way to discuss 
polymer-based nanocomposites, because the processing methods used and the 









a) Nanosphered and nanopatirculated composites 
 
 Nanoshperes or nanoparticles can be dispersed throughout a continuous 
matrix to induce porosity,69 to improve mechanical properties of a bulk scaffold 
as a reinforcement phase70 or a crosslinking agent71 and as a drug delivery 
vehicle.72 They can also be used as building blocks to establish scaffolds by a 
bottom-up approach without a surrounding matrix material. Particulate building 
blocks can also be used to prepare 3D stand-alone scaffolds without surrounding 
material through rapid prototyping,73 random packing74 or directed assembly.75 
Figure 5 




Rapid prototyping uses a computer-aided design to produce 3D constructs with 
customizable architecture using nanospheres as building blocks.73 
  Nanopaticulated composites can be produced in a random packing 
technic or in a direct assembly. In a random packing technic, composite gels are 
putted up together in a structurally random way, which leads to poor integrity of 
these gel-based scaffolds resulting from weak interparticle interactions and 
consequently poor mechanical stability.74 To preserve the agglomeration of 
nanosphere formulation after implementing these scaffolds, maintaining the 
particles together, crosslinkers and compatibilization agents have been 
investigated.75 On the other hand, directing the assembly by introducing 
interparticle forces (such as electrostatic forces or hydrophobic interactions), can 
produce formulations with enhanced structural integrity and mechanical stability 
without the use of compatibilization agents or crosslinkers.75 Therefore, this 
technique allows for a level of structural organization that ensures good 
mechanical properties. Clinically, these techniques have been used to produce 
injectable gels which act as scaffolds for bone regeneration in minimally invasive 
surgery.76  
When dispersing nanoparticles in a polymeric matrix, two main alternatives 
can be considered: they can be dispersed in the polymeric matrix during the 
polymer synthesis or after the polymer synthesis being complete.65 By blending 
the nanoparticles in pre-synthesized polymer matrixes, it is possible to have a full 
control over both the nanoparticles and the matrix. The preparation of most of the 
nanoparticles and nanomaterials can be divided into four main methods.65  
I. The wet method, in which nanoparticles are prepared in a medium using 
a sol-gel technique, emulsion approaches or the intercalation polymerization; 
II. The dry method, that includes preparing of nanoparticles using methods 
such as the abrasive, burning, gas impinging and collision approaches, high-
energy ball milling processes; 
III. The evaporating method, where nanoparticles are prepared using 
chemical vapor deposition or the gas deposition approach, like laser gas vapor 
deposition.  
IV. The sedimentation method, for special nanocomposites that possess 
heavy weight selection particles.  
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In ceramic-polymer nanocomposite processing, wet and dry methods are 
used very often, being the sol-gel technique one of the most used. It consists in 
a series of hydrolysis and condensation reactions that transform a solution, which 
has colloidal particles dispersed in it, into a gel, where both liquid and solid are 
dispersed in each other, through low temperature methods.  
 
b)  Nanofiber composites  
 
An important class of nanostructured biomaterials on which intensive 
research has been carried out is nano-fibrous materials, especially biodegradable 
polymer nanofibers. In this specific material, nanofibers are dispersed in a 
biodegradable polymer matrix. The large surface-area-to-volume ratio of 
nanofibers combined with their porous structures favours cell adhesion, 
proliferation, migration, and differentiation, as it was already discussed. There are 
three main techniques to produce nanofibers: phase separation, self-assembly 
and electrospinning.77 Nanofiber mats can be morphologically similar to 
extracellular matrix (ECM) of the natural tissue, which is characterized by a wide 
range of pore diameter distribution, high porosity, effective mechanical 
properties, and specific biochemical properties.78  
Phase separation, for instance, is a technique often used to produce 
nanofibrous scaffolds.77 This process is based on thermodynamic demixing of a 
homogenous polymer solvent solution into a polymer-rich phase and a polymer-
poor phase. Cooling the solution to a specific point causes this separation. 
However, usually there is lacking of interconnected macropores, so this 
technique is often combined with other scaffold fabrication techniques (e.g. 
particle leaching) to allow broader control over the scaffold architecture.79,80 With 
this technique, nanofibers with a range of diameters of 50 to 500 nm are 
produced. Ma et al.81 have used this technique to produce a PLLA fibrous 
structure from a PLLA/THF solution to be used in regeneration scaffolding 
materials that provide a better environment for cell attachment and function.   
Self-assembly is the most complex technique and it allows the creation of 
nanofibers with very small diameters (a few to 100 nm). It basically consists on 
an autonomous organization of components that are able to assemble at the 
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molecular level.77,82 Being a natural process for several essential biological 
components including nucleic acid or protein synthesis, self-assembly technology 
usually incorporates some specific biological components of the extracellular 
matrix (ECM), closely mimicking the ECM assembly process.80 In this process, 
molecules require some specific configurations to be assembled into nanofibers. 
Molecules that meet this requirements are peptide-amphiphiles (PAs),80 
oligopeptides, synthetic diblock/triblock copolymers83 and dendrimers.84 Both 
self-assembly and phase separation have the disadvantage to create only short 
strands of nanofiber.80 
Another example is electrospinning, which in contrast, represents the most 
reliable method to simply fabricate long continuous strands of nanofibers with a 
diameter ranging from nanometers to microns (50–1,000 nm). Besides being 
simple, it is relatively quick and cost-effective.85 This process involves subjecting 
a polymeric solution to a high electric field, which overcomes the surface tension 
of the solution and drives the ejection of a polymer jet. The charged polymer 
solution or melt is ejected, dried and solidified onto a grounded substrate. The 
ejected polymer solutions repel each other during the travel to the grounded 
collector, which forms thin fibers after solvent evaporation. By controlling the 
spinning conditions, the resulting fibers can range from about 0.02 μm to about 
20 μm.86 Many electrospun nanofibrous biomaterials have been investigated as 
tissue regeneration scaffolds.78,86 Materials used in electrospinning can be 
natural macromolecules such as collagen, chitosan, silk fibroin; synthetic 
biodegradable polymers such as PGA, PLGA, PLLA, PCL; and combinations of 
these natural and synthetic polymers. In addition, various substances (proteins, 
growth factors, and hydroxyapatite) can be incorporated into nanofibrous 
materials during electrospinning. Therefore, electrospun nanofibrous 
biomaterials have been explored to engineer various tissues. However, 
significant challenges still exist in using this technique to fabricate complex 3D 
scaffold shapes or to generate designed internal pore structures, limiting its 




























II. Materials and Methods 
 
Search Strategies  
 
In order to perform a bibliographic review as complete as possible, data was 
extracted and selected from scientifically relevant databases, in this case 
ScienceDirect and PubMed.  
In a first stage, the following combination of words was used in both online 
data-bases: “Bone AND Regeneration AND Nanocomposite AND Polymer AND 
maxillofacial AND NOT review”. In the PubMed database, 5 results were found 
and in ScienceDirect, 33. It was then realized that this combination of words 
restricted too much the online search too much, so other MeSH terms were 
selected and integrated in the combination. The word “cranial” was selected 
(replacing the word “maxillofacial”), to provide articles about bone regenerative 
measures using nanocomposites among the whole cranial complex and not just 
the maxillofacial area. The MeSH term “augmentation” was added as well, in 
order to include articles about the use of regenerative techniques in alveolar bone 
augmentation. The different MeSH words and combinations, as well as the 
obtained results are included in results diagram (Annex 1) and can be summarized 
as follows:  
 “Bone AND Maxillofacial AND Regeneration AND nano composite AND 
polymer NOT review”, with the particularity of having the nanocomposite written 
separately (nano composite), obtained 5 results in PubMed and 73 in 
ScienceDirect; 
  “Bone AND Cranial AND Regeneration AND nanocomposite AND 
Polymer NOT review”, in which the word “Maxillofacial” was replaced by the word 
“cranial”, obtained 9 results in PubMed and 27 in Science Direct; 
  “Bone AND cranial AND regeneration AND nano composite AND 
Polymer NOT review”, the same search performed before, with nanocomposite 
written separately (nano composite), obtained 13 results in PubMed and 60 in 
ScienceDirect; 
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  “Bone AND maxillofacial AND augmentation AND nanocomposite AND 
polymer NOT review”, in which the word regeneration was replaced with the word 
“augmentation”, obtained 0 results in PubMed and 6 in ScienceDirect; 
  “Bone AND maxillofacial AND augmentation AND nano composite AND 
polymer NOT review”, the same search performed before, with the word 
nanocomposite written separately (nano composite), obtained 0 results in 
PubMed and 23 in ScienceDirect.  
Moreover, relevant online databases providing information about clinical 
trials in progress (www.clinicaltrials.gov, www.centerwatch.com/clinicaltrials, 
www.clinicalconnection.com) were initially considered and checked, using the 
combination of words: “Bone AND Regeneration AND Nanocomposites”. 
However, no results were found. 
 
Study Selection  
 
The total number of results from the all the different online searches is 255. 
From these, duplications were found and excluded as well as studies that were 
published before 2009. 150 articles remained for individual selection based on 
the inclusion and exclusion criteria. Titles and abstracts of all remaining reports 
were read to make sure that the exclusion criteria were applied properly. 
 
Inclusion and Exclusion Criteria 
 
 Eligibility criteria included in vitro studies that evaluated the biocompatible 
and stimulating capacity of materials composed of nano-ceramic particles 
dispersed in a polymeric matrix with bone-related cells, in vivo studies that 
comprehended the investigation of the mechanical, structural and bioactive 
behavior of polymer-ceramic nanocomposites, clinical trials performed to 
evaluate the overall performance of nanocomposites in humans, specifically in 
the craniomaxillofacial region and pshysicochemical studies of novel 
regeneration systems including polymers and ceramic nano-particles. 
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 The exclusion criteria were: case reports and case studies, book chapters, 
conference proceedings, papers written in other language that not English, 
articles that are published in open access magazines, in vivo studies with a small 
amount of samples (less than 5), in vitro studies using cells that are not bone-
related, studies that use micro-sized composites and finally articles that state 
about nanocomposites without a both ceramic and polymeric constitution. 
 
Data extraction and meta-analysis  
 
 From the studies included in the final analysis, the following data was 
extracted: year of publication, type of study (in vitro or in vivo, since no relevant 
clinical trials were found) and country of origin of the research.  
In a second stage, the in vitro and in vivo studies were separated and 
different information was analyzed within each group. In the in vitro group, the 
selected information was: polymeric matrix, nano-filler, nanocomposite 
specifications, type of cell used for the investigation, type of in vitro evaluation 
and final outcome. In the in vivo group, the selected information was: polymeric 
matrix, nano-filler, nanocomposite specifications, type of animal used to perform 
the study and its characteristics (age and weight), site of implementation of the 





























































In the present analysis 150 studies were considered for evaluation, as result 
of the performed searching process. Out of these, 30 met the inclusion criteria.  
 
1. Year of publication 
 
Figure 6 represents the amount of relevant papers published between 2009 
and 2013.  
 
 
It is noted that the majority of papers concerning the aim of this study, 













Relevant papers published per year between January of 2009 and 2014 
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2. Study design 
 
Among the 30 articles considered for this thesis, three types were found: in 
vivo studies, in vitro studies and both in vitro and in vivo studies. In order to 
simplify, articles including both in vivo and in vitro studies were divided and the 
studies were considered separately.  
Figure 7 represents the percentage of studies included for this thesis, in 
which 63 % are in-vitro studies, 37% are in vivo studies. The majority of studies 









Amount of in vitro and in vivo studies. 
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3. Country of Origin  
 
 The analyzed articles are originated from different parts of the world. By 
extracting the country of origin of these articles, it was possible to conclude the 
ones that provide a higher contribution in the research of polymer-ceramic 
nanocomposites applied to bone regeneration. Figure 8 presents the distribution 
of articles according to their country of origin. In articles that resulted from a 
collaboration of different countries, the country of the corresponding author was 
de one taken in consideration. 
 
 
After analyzing the above figure, it is possible to conclude that China, USA, 
Iran and Republic of Korea are the countries that published the highest amount 
of articles about this theme, since 2009 until now.  
  
Figure 1 




















Different counties of origin of the authors of the included studies 
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4. Publishing Journal 
 
Figure 9 represents the journals that include the articles used for the 
development of this bibliographic review.  
 
Among them, 20% of the articles were extracted from Biomaterials (with a 
5-year impact factor of 8,911), 13% from Materials, Science and Engineering 
(with a 5-year impact factor of 3,076) and 10% from Acta Biomaterialia (with a 5-
year impact factor of 6,191). There are two journals that possess a representation 
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Journals with representation in the present thesis 
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an impact factor of 2,158) and Clinical Oral Implant Research (with an impact 
factor of 3,123). All the other journals have a representation below this 
percentages.  
This journals can be grouped into three major categories: (a) journals that 
are more generalist in the biomaterial area, focusing on the publication of articles 
that study biomaterials characterization and implementation for the generalized 
medical area (eg. Biomaterials, Acta Biomaterialia and Journal of Biomaterials 
Science, polymer edition), (b) journals that publish articles regarding the use of 
biomaterials in the orthopedic area, which includes innovations concerning bone 
tissue, or specifically bone tissue investigation and (c) journals that publish 
specific innovations in the oral and maxillofacial area, including the research of 
novel materials developed specifically for this area (eg. Clinical Oral Implant 
Research, International Journal of Oral and Maxillofacial Surgery, J. Oral and 
Maxillofacial surgery). In order to understand which type of journal published the 












the biomaterial area 
in general
80%








Types of journals publishing more articles about polymer-ceramic 
nanocomposites in the maxillofacial area 
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It is explicit that 80% of the journals that include the articles used in this 
dissertation belong to the biomaterials area. Just 13% are journals regarding the 
maxillofacial area. 
 
5. Materials Selection  
 
 
a) Polymers  
 
As referred in the introductory section, polymers can be biodegradable or 
non-biodegradable and natural or synthetic. Furthermore, the origin of the used 
polymers was analyzed, in the attempt to establish a tendency of which polymers, 
natural or synthetic, are used the most in the polymer-ceramic nanocomposite 
field directed for bone regeneration, in the last 5 years. Figure 11 demonstrates the 
analysis performed.  
 
It was concluded that among the polymers chosen by the authors of the 30 








Origin of polymers used in the cosidered articles 
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extracted from natural sources. The polymeric constitution of nanocomposites in 




In order to understand which nanofillers are used the most in the considered 
articles, Figure 12 was created. It is however important to refer that some of the 
articles considered include non-ceramic nanofillers as a second or third nanofiller, 
that joins forces with the ceramic component, with the purpose of attributing 
specific structural or biological properties. These components were considered 
as well.  
 
 
It is evident in Figure 12, that the majority of the articles use nano-
hydroxyapatite as the ceramic nanofiller of the investigated nanocomposites. 
Moreover, additional non-ceramic fillers (nano-titanium92,103,104 and nano-





























The nanofillers chosen specifically in the in vivo and in vitro assays will be 
analyzed later in this review.   
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6. In vivo Studies  
 
 The in vivo studies discussed in this dissertation can be divided in two 
major groups: (a) The ones that aim to evaluate the in vivo biocompatibility of the 
scaffolds by implanting them in a non-osseous environment (sub-cutaneous or 
muscular) and evaluating the body’s immunity response towards the scaffold and 
(b) the ones that aim to analyze the bone regenerative capacity of the scaffolds 
by implanting them in artificially created bone defects and evaluating their 
capacity of stimulating bone regeneration, by replacement of the scaffold for new-
formed bone. Table 4 and 5 address the two distinct groups separately. They 
explore the different articles analyzing the following parameters: Composition and 
specifications of the used nanocomposites, animal characteristics and site of 

























Type of animal 


















nHa was extracted from 
egg shells that underwent 
a calcination procedure. It 
was then incorporated in 
the SF scaffold by dipping 
the scaffold in a nHA 
supersaturated solution. 
Sixteen 4 month-
old New Zealand 
white rabbits. 




created in each 
side of the 
cranial midline 
4 and 8 
weeks 
Different scaffolds were 
implanted in the animals: 
pure nHA, pure SF and 
nHA/SF. The samples were 
fixed, sectioned and 
evaluated 
histomorphometrically. 
The nHA was evenly distributed in the SF 
web shaped scaffold. The scaffold that 
presented a higher amount of bone 
formation was the pure nHA at 8 weeks. 
There was a low bone regeneration in the 
SF/nHA scaffold, attributed to the slow 










The PECE was freeze-
dried and reduced to 
powder. This powder was 
mixed with nHA, and 
collagen and an injectable 
hydrogel composite was 
obtained, with 60% of 
PECE, 10% of collagen 
and 30% of nHA. 
9 adult New 
Zealand White 
rabbits 
Weight: 2,5 to 3 Kg 
Two 10 x 5 x 2 
rectangular 
defects were 
created in both 
right and left 
pariental bones 
4 and 20 
weeks 
The created bone defects 
were injected with the 
nanocomposite, and its bone 
regeneration capacity was 
assessed though 
radiographic and histological 
studies. 
The filled bone defects showed a high-
density tissue in the middle space at the 4th 
week, that grew until the defect was 
completely closed by new formed bone, at 










were synthesized. nHA 
was incorporated and the  
scaffold was freeze-dried. 
4-year-old adult 
goats 
Weight: 70 ± 15 Kg 





1 and 6 
months 
Defects were filled with 
Matrix + nHA or left empty. 
Histological evaluation was 
performed. 
Mineralization of the bone defect started at 1 
month and was clearly evidenced at 6 
months. The mineralized tissue completely 
filled the critical size bone defect after 6 









3 different scaffolds were 
produces: nHA/PLLA 
scaffold alone, nHA/PLLA 
scaffold combined with 
rhBMP-2 and nHA/PLLA 
combined with P24, a 









created at the 
center of the 
right parietal 
bone. 
6 and 12 
weeks 
The 3 different scaffolds 
were implanted. The 
samples were evaluated 
while the animals were alive, 
by radiographic examination. 
Histological evaluation was 
performed to the fixed 
harvested calvariae samples. 
At 6 weeks, the rats implanted with scaffolds 
containing rhBMP or P24 showed new bone 
mineralization, while the ones implanted with 
nHA/PLLA scaffolds didn’t exhibit bone 
formation at all. With 12 weeks, all scaffolds 
demonstrated bone formation, but the ones 
with groth factors showed a bigger amount 
of bone formation. 
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Type of animal 
















bought, as well as the 
e-PTFE membranes 




rats, 12 weeks 
old. 
Weight: 208 to 
320g 
Two calvarial 
defects, 5mm in 
diameter were 
created in the 
bilateral sides in 
the midline 
1, 4 and 8 
weeks. 
The rats were divided in 3 
groups: bone defect 
covered with a nHA/PA66 
membrane with a e-PTFE 
membrane and with a 
PA66 membrane. After the 
rats were killed, the 
harvested bone were 
analyzed and serological 
tests were performed. 
In defects covered with nHA/PA66 and e-
PTFE, the defects started with a small 
amount of bone-like particles in the first 
week. In the 4th, the density increased 
remarkably and at the 8th week, the bone 
defects were closed by new developed 
bone. The defect covered by a PA66 













Two full  -
thickness 
rectangular 
defects of 5 x 5 
mm in the 
sagittal suture 
(cranial defects) 
10 and 20 
weeks 
One of the defects was 
implanted with 
nHA/chitosan scaffolds 
seeded with BMSC cells 
and the other was 
implanted with the scaffold 
without cells. Blank groups 
were left untreated. 
After 10 weeks, the bone defects that were 
implanted with nHA/chitosan/BMSC 
scaffolds presented regenerated bone in 
the central part of the repaired area. The 
other two just presented fibrous tissue. 
After 20 weeks, the first defect was almost 
completely repaired, whereas the other two 





blocks were produced 
with a porous 
structure of 65-70% 
15 New Zealand 
white rabbits 
Weight: About 3,5 
Kg. 
15mm x 10 mm 
bone defect 
created in the 
both sides of 
body of the 
mandible. 
4, 12 and 24 
weeks. 
The defects in one side of 
the mandibles were 
implanted with nHA/PA 
blocks and the other side 
was kept empty, for 
comparison purposes. 
Radiographic examinations 
were performed before the 
animals were sacrificed. 
Mandibles were removed, 
cleaned and prepares for 
histologic testing. 
There was no inflammation or rejection of 
the scaffolds. After 4 weeks of 
implementation, a beginning stage of 
mineralization was found around the 
nHA/PA blocks. The mineralization 
progressed continuously and at the 24th 
week, the density of bone formed in the 
defect filled with the nanocomposite was 
similar do the host’s bone. The control 
group showed a reduction of the defect 
size, but it was not regenerated. 
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Type of animal 














A so-called GEMOSIL 
porous scaffold derived 
from a formable paste by 
a new powder process 
consisting of coating, 
kneading and hardening. 
A buffer solution and an 
enTMOS coating were 
added. Nanocrystals 
were interwoven inside 
the aminosilica matrix 
after hardening. 
TiO2 was incorporated to 
a part of this powder. 
6 Sprague-Dawley 
rats, 11 to 13 
week old. 











Nanocomposites with and 
without TiO2 were implanted in 
the bone defects. 
Both nanocomposites revealed new 
bone formation 8 weeks after 
implantation. However, the scaffold with 
titanium additives had a higher level of 
bone density. This suggests that 












0,3mm tick membranes 
were produced. The 
silver concentration is 0,5 
wt% and the titania 
concentration is 2.5 wt%. 
nHA was incorporated 
though a precipitation 
reaction. A PA66 pure 
membrane was produced 
as a control membrane 
27 Sprague-
Dawley rats 








in the skull of 
each rat 
1, 4 and 8 
weeks 
The total amount of rats was 
divided in three groups: the first 
received Ag-nHA-TiO2 – PA66 
membranes, the second 
received pure PA66 membranes 
and the third group had its 
defect left empty for control. 
Radiographic and histological 
tests were performed. 
The first group showed some bone 
growth in the edges of the defect at the 
4th week. At the 8th week, these defects 
looked similar to the surrounding bone, 
which means that the defect was 
regenerated. The defects covered with 
pure PA66 membrane and the ones left 













produced by varying the 
amounts of each 
component: 
nanocomposites with and 
without chitosan were 
developed. 








4 and 8 
weeks 
The animals were divided in tree 
groups: In one, the bone defects 
were filled with the injectable 
nanocomposite having a 
nHA/chitosan composition, in 
the second, nanocomposites 
were composed only by HA and 
in the third defects were left 
empty. 
After 4 weeks, both composites were 
divided in islands and some new formed 
bone is detectable, mainly in the edges. 
After 8 weeks, histology showed more 
regenerated bone in the nanocomposite 
containing nHA/ chitosan, when 
compared to the HA nanocomposite. 
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Type of animal 



















nAg – HA – TiO2 
membranes were produced 
with ≈ 0,2 mm in thickness 
and 10mm in diameter. 
e-PTFE membranes were 
produced as well, for 
comparison purposes. 
27 male  Sprague-
Dawley rats 





1,4 and 8 
weeks 
The nAg – Ha – TiO2 
membranes were implanted in 
the defects and fixed by a 
medical adhesive. E-PTFE 
membranes were placed in the 
other defects for control and 
some defects were left empty.  
Rats were killed and block 
sections of the defects were 
removed and analyzed by 
radiographic and histological 
techniques. 
In defects implanted with the  nAg – Ha 
– TiO2 membranes showed bone 
trabecula network at the 1st week. At 
the 4th week, the density of the 
trabecula increased and at the 8th 
week, the entire defects were occupied 
by new bone (very similar to the 
surrounding bone). In e-PTFE 
implanted defects, the trabecula 
network just appeared at the 4th week, 
but the defect was closed at the 8th 











80/20 w% SF/PAA porous 
scaffolds were produced 
and alternate soaking 
process was used to grow 
apatite nanocristals on the 
silk fibers surface. 
BMSCs were cultured in 
vitro to generate a cell 
material complex for in vivo 
testing. 
17 adult male 
Mongrel dogs, 
aged 18 months 
Weight: 15 to 20 
kg 







1, 3, 6 and 12 
months 
The animals were divided in five  
groups, in which each group had 
its bone defect filled with: (A) 
SF/PAA membranes; (B) 
SF/PAA/nano-apatite 
membranes; (C) SF/PAA 
membranes with seeded 
BMSCs; (D) SF/PAA/nano-
apatite membranes with BMSCs; 
(E) Autogenous bone. 
Radiographic and histological 
assays were performed. 
The group with best results was group 
(D): Callus was observed until the 3 
months pos-operation; at 6 months, the 
volume of new formed bone increased 
very much and at 12 months, the 
mandibular defect was complete and 
no differences were seen to the 
proximal normal bone. Group (C) 
showed increased bone formation but 
failed to fill completely the defect after 
12 months. Other groups failed to 






70/30 wt% Chitosan-Silica 
xerogel hybrid membranes 
were fabricated through a 
sol-gel technique, followed 
by freeze drying.  Pure 




rats, aging 13 
weeks 









In each animal, one defect was 
covered with a pure chitosan 
membrane for control and the 
other was covered with the 
70/30 wt% Chitosan-Silica 
xerogel hybrid membranes. 
Animals were sacrificed and the 
implantation site was 
histologically analyzed 
No significant inflammation reaction 
was observed around either 
membranes. The collagen membrane 
was partially, but not completely 
degraded and substituted by new 
formed bone, while the hybrid 
membrane was completely degraded 
and the defect site was replaced by  
new bone and some collagen fibers. 
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Type of animal 












nHA produced by a wet 
synthesis and a 
hydrothermal treatment was 
gradually added into the PA 
matrix and the mixture was 
set in room temperature for 
coprecipiatation to occur. 
54 New Zealand 
white rabbits. 
Weight: about 3 
Kg. 
3cm incision 
on the jaw of 
the rabbits; 
12 x 8 mm2 
critical size 
defects in the 
bucco-lingual 
part, in both 
sides of the 
mandible. 
4, 8 and 16 
weeks. 
The rabbits were divided in 3 
groups, regarding the implant 
that they would receive: 1- 
Scaffolds seeded with BMP-7 
traduced MSCs; 2- Scaffolds 
seeded with osteogenically 
cultured MSCs alone and 3- 
Pure nHA/PA scaffolds. 
After 4 weeks, new bone was observed in 
all mandibles, but the one treated with 
scaffolds seeded with BMP-7 traduced 
MSCs, had a bigger bone density than 
the others. At 8 weeks, the situation 
remained the same. At 16 weeks, all 
mandibles had a comparable 
osteointegration scenario. 
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Type of animal 

















macroporous scaffolds were 
synthesized. nHA was 
incorporated and the  
scaffold was freeze-dried. 




pockets in the 
dorsum of the 
rats 
15, 30 and 60 
days 
Matrix and matrix + nHA 
were inserted into the 
animals and analyzed 
histologically. Mineral 
content was evaluated. 
Matrixes with nHA revealed a high degree 
of mineralization through time. In contrast, 










nAg – HA – Tio2 membranes 
were produced with ≈ 0,2 
mm in thickness and 10mm 
in diameter. 
e-PTFE membranes were 
produced as well, for 
comparison purposes. 







pockets in the 
neck region 
4 and 8 weeks 
NAg-HA-Tio2/ PA66 
membranes and e-PTFE 
membranes were inserted 
in subcutaneous spots and 
its biocompatibility in vivo 
was assessed, using the 
collected membranes and 
adjacent tissue in 
histological observation. 
No obvious inflammatory reaction was 
observed in either membranes after 8 
weeks of implantation. Histologically, both 
membranes were covered with granulation 
tissue, densely populated by cell nuclei. At 
the 8th week, the NAg-HA-Tio2/ PA66 
membranes showed less granulation tissue 
that the e-PTFE membranes. Therefore, 
NAg-HA-Tio2/ PA66 membranes were 











The PECE was freeze-dried 
and reduced to powder. This 
powder was mixed with nHA, 
and collagen and an 
injectable hydrogel 
composite was obtained, 
with 60% of PECE, 10% of 
collagen and 30% of nHA. 
12 healthy Wistar 
rats 
Weight: 120 to 
150g 
Pouch in the 
dorsal muscle 
3, 7 and 14 
days 
The in vivo biocompatibility 
was accessed by injecting 
0,5ml of the composite into 
each muscle pouch. The 
rats were then sacrificed 
and the implants as well 
as surrounding tissue were 
analyzed. 
After 7 days, a slight inflammatory reaction 
appeared due to the implant’s degradation. 
It was proven that the pECE/nHA/collagen 










macroporous scaffolds were 
synthesized. nHA was 
incorporated and the  
scaffold was freeze-dried. 
4-year-old goats 




1 and 6 months 
Matrix and matrix + nHA 
were inserted into the 




Matrixes with nHA revealed a high degree 
of mineralization starting from the periphery 
to the center. In contrast, no mineralization 
occurred in the Matrixes implanted alone. 
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Type of animal 





















produced by varying the 
amounts of each 
component: 
nanocomposites with and 
without chitosan were 
developed. 
12 male  
Sprague-Dawley 
rats Weight: 320 -
350 g 
Dorsum muscle 





day and the 
tissue was 
removed after 1, 
2, 4 and 6 
weeks 
The nanocomposite was 
injected in the rat’s 
muscle and fixed in situ. 
After the incubation 
period and through a 
surgical procedure, the 
nanocomposite with the 
surrounding muscle 
tissue was removed and 
it’s biocompatibility as 
assessed. 
There were no obvious inflammatory 
responses in the daily observations. 
Histological observation shows that the 
nanocomposite contained immunological 
cells after 1 week and that these cells 
increased through time, starting to divide 
the nanocomposite after 6 weeks. No 
fibrous capsule was observed. 
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a) The choice of animal models among in vivo studies  
 
Figure 13 represents the percentage of laboratory animals used in the in vivo 
studies. Figure 13 – A represents the laboratory animals used in the osseous 
implantations, while Figure 13 – B represents the laboratory animals used in the 





When analyzing the type of laboratory animals, Sprague-Dawley rats 
91,92,100,103,104,107,108,110 are the most commonly used in these studies, followed by 
New Zealand rabbits 34,93,105,106. In a smaller proportion, Goats 95, Balb/c mice 95, 




























Laboratory animals used in the in vivo studies 
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b) The choice of Polymers  
 
In order to understand which polymers were used the most as matrixes of 
the studied nanocomposites in the in vivo studies, an accounting was performed. 
Figure 14 shows the percentage of polymers used: Figure 14 – A shows the polymers 
chosen for the osseous implantation and Figure 14 – B shows the polymers chosen 
for the non-osseous implantation.    
 
 
When analyzing the osseous implantation, polyamide (in its normal or in its 
aliphatic state – polyamide 66) 34,91-93,104 stands out as the most chosen polymer 
to integrate the matrix of the nanocomposites, followed by collagen 106-108, that 
was used in 16% of the studies. Chitosan 100,110, Silk Fibroin 105,109 and PECE – 
a triblock copolymer composed of poly(ethylene glycol) - poly(ε-caprolactone) - 
poly(ethylene glycol) 106 have a representation of 11%.  
In the non-osseous implantation, the innovative Pullulan/ Dextran 95 polymer 
has a bigger representation, since it was subjected to 2 studies of non-osseous 
biocompatibility in different animals. The other polymers have the same 











































c) The choice of nanofillers 
 
Figure 15 represents the percentage of nanofillers used in the studied 
nanocomposites in both osseous and non-osseous implantation.  
 
 
Regarding the most used nanofillers, nano-hydroxiapatite (nHA) is the most 
selected nano-ceramic , being used in almost all the in vivo studies contemplated 



















7. In vitro Studies  
 
 
The 24 in vitro studies considered for this review can be divided in 3 major 
groups based on their model to evaluate the in vitro response to the biomaterial 
in study: (a) the ones that use stem cells to evaluate if the nanocomposite is able 
to stimulate their differentiation in a osteogenic cell line, by having the right 
stimulating constitution (b) the ones that use already differentiated osteogenic 
cells and (c) the ones that use stimulated body fluid, to assess whether the 
nanocomposite is capable of producing surface apatite particles, when immerged 
in this solution that replicates in vivo fluids, or not. Figure 16 demonstrates the 
percentage of studies that call upon each of this strategies and Table 6 
reproduces their specifications.  
 
The processing techniques used to produce the final nanocomposites can 
vary according to the involved material and their specifications. To detail these 
complex techniques and biochemical effect elicited by the materials on the tissue 
is not the goal of this dissertation. Moreover, the technical procedures for the 










Studies using stem cells, osteogenic cells and Stimulated Body Fluid 
 
57 
relevant but not exhaustively described since this was not the goal of the present 
thesis, as well.  
In Table 6 are presented, in a comparative way, the different aspects about 
the retrieved in vitro studies including: the polymeric and nanofiller composition 
of the nanocomposites, their specifications, type of cells used to perform the 






Table 6 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 





Nano – filler 
Nanocomposite 
specifications 
Type of cell 
used 
Specifications of the 
cell 






3 different scaffolds 
were produced for 
comparison: nHA/ 
Chitosan, produced 












stem cells were 
isolated from femurs 
and tibias of Sprague-
Dawley rats. 
The morphology of the 3 
different scaffolds was 
evaluated. 
For the cell culture, cells were 
seeded on top of the 3 different 
scaffolds and their proliferation 
and characterization was 
performed. 
BMSC showed a different cell-morphology on 
the nHA/chitosan scaffold, when compared to its 
shape in the other 2 scaffolds. 
The cells differentiated and proliferated better on 
the nHA/chatiosan scaffold. Is was suggested 
that nHAP/ Chitosan induces the activation of 
integrin, which activates bone morphogenic 













produced though a 
mixture of colloidal 
suspensions. Various 
concentrations of 





The structural properties of this 
injectable material were 
assessed and an in vitro cell 
culture was performed to 
analyze its biocompatibility, for 
4h, 1, 2, 4 and 7 days. 
The alginate concentrations didn’t show 
significant influence in the nanocomposite 
homogeneity and in the average pores size. The 
molar concentration of the colloidal solutions can 
make this properties vary. As for the cell culture 
test, the cells adhered, spread and survived very 











was incorporated and 
the  scaffold was 
freeze-dried. 
Stem Cells 
Human bone marrow 
stromal cells 
(HBMSc) extracted 
from the femoral 
diaphysis or iliac 
bone of 30-80 aged 
patients. 
The scaffold was analyzed to 
verify the quality of dispersion of 
the nHA in the matrix. 
The behavior of HBMSc with the 
scaffold was assessed, with and 
without addition of nHA. 
It was possible to find multicellular aggregates in 
both scaffolds, with and without nHA. However, 
the supplementation with nHA increased the 
proliferation of cells. 
Table 6 
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Table 6 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 
applications in the maxillofacial context (continued) 
 
 
Ref. Polymeric Matrix Nano – filler 
Nanocomposite 
specifications 
Type of cell 
used 
Specifications of the 
cell 





Silk Fibroin (SF) and 
polyaspartic acid (PAA) 
Nano-apatite 
80/20 w% SF/PAA 
porous scaffolds were 
produced and alternate 
soaking process was 
used to grow apatite 





Bone marrow stromal 
cells extracted from 
mongrel dogs, 18 
months old and 
weighing from 15 to 
20 Kg. 
Scaffolds were seeded with 
bMSCs and incubated for 
14 days. 
Cell clones were formed 5-7 
days after initial seeding and 
after two-weeks, bMSCs spread 
and differentiated and in the end 
of the incubation period, 
osteoblastic cells were positively 
identified in the scaffolds. It was 
possible to find cells attached to 
the porous structure, as well as 
fibril network of extracellular 






Scaffolds were fabricated 
with different ratios of 
nHA/PCL by a melt-
molding and a leaching 
technique. 
Stem Cells 
Bone marrow stromal 
cells (BMSc) 
extracted from Dogs. 
Scaffolds were 
characterized before and 
after a 6 months in vitro 
degradation. Cell culture 
was performed to evaluate 
the cytocompatible 
properties of the scaffolds. 
The degradation test showed 
that this scaffold can retain 
relatively stable architecture and 
mechanical properties for at 
least six months. The porosity 
level of the nHA/PCL 
nanocomposites is around 
70%.They have good 
cytocompatibility 





A multi layered fiber 




electrosppining, adding of 
1% of a hydrogel 




Bone marrow stromal 
cells  (BMSc), 
extracted from 
Winstar rats 
The laminated composites 
were characterized, its 
degradation characteristics 
were assessed and the 
BMS cells were seeded 
and analyzed at 7, 14 and 
21 days. 
This scaffold proved to have a 
slow fiber degradation rate for 
structural stability and a fast 
hydrogel degradation rate to 
increase the space for cell 
migration and ECM production. 
The HA nanocrystals suspended 
in the hydrogel phase proven to 
have an osteoconductive 
potential, promoting the 
differentiation and mineralization 
of the BMS cells. 
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Table 6 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 





Nano – filler 
Nanocomposite 
specifications 
Type of cell used 
Specifications 
of the cell 
Method of in vitro 
evaluation 
Outcome 








0,3mm tick membranes were 
produced. The silver 
concentration is 0,5 wt% and 
the titanium concentration is 
2.5 wt%. nHA was incorporated 




cell line -  MG-
63 osteoblast 




mechanic tests were 
performed. 
Cytocompatibility was 
assessed though cell 
culture in top of the 
membrane, followed by 
cell morphology 
examination, viability 
evaluation and cell 
differentiation assays. 
Characterization of the membrane 
confirmed well dispersed spherical 
titanium nano-particles in between needle-
like crystals, among the matrix. The 
addition of silver and titanium did not 
change the mechanical properties of the 
nHA/PA66 membrane. In the cell culture 
evaluation, cells adhered and spread well 
on the membranes. The addition of silver 
and titanium decreased the cell viability, 
but did not affect the differentiation of 
MG63 cells. 




A so-called GEMOSIL porous 
scaffold derived from a 
formable paste by a new 
powder process consisting of 
coating, kneading and 
hardening. A buffer solution 
and an enTMOS coating were 
added. Nanocrystals were 
interwoven inside the 
aminosilica matrix after 
hardening. 
To a part of this powder, TiO2 
was incorporated. 
All components were 
added in different 







All the created scaffold 
were characterized and 
mechanically tested to 
assess which one 
possessed better 
characteristics for in 
vitro assessment. 
Cells were seeded on 
the scaffold to access 
its biocompatibility and 
to determine the cellular 
metabolic activity. Cell 
differentiation was 
evaluated as well. 
The amount of enTMOS coating did not 
affect the properties of the 
nanocomposites. However, the amount of 
TiO2 decreased the hydrophilicity of the 
scaffolds, promoting cell adhesion. The 
scaffolds with TIO2 were the ones that 
promoted more cell differentiation and 
proliferation in the in vitro studies. 
This scaffolds are not cytotoxic. 
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Table 6 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 










of the cell 








Colloidal nHA was 
synthesized via co-precipitation 
method inside the PVA aqueous 
solution and then freeze dried, 
producing a nanocomposite. 
Scaffolds with different amounts 
of both components and in 
different pH values were 








The scaffolds were 
characterized and 
analyzed regarding its 
mechanical properties. 
The in vitro cell-material 
interaction study was 
performed seeding the 
cells on top of the 
scaffolds for 4 days at 
37 °C. 
For producing this scaffold, the optimal pH 
value that permits the best interaction 
between both components and allows the 
precipitation of nHA in the structure is 9. It 
was proved that increasing the polymer phase 
in the scaffolds enhanced mechanical 
properties such as toughness and the elastic 
modulus. The cell culture test showed that 
this scaffold allows cell to spread and attach 






The gel components were 
prepared and the nanofillers 
were dispersed. The scaffold was 
then freeze dried to create a 










The scaffold was 
characterized and its 
mechanical properties 
were assessed though 
compression tests. Cell 
attachment, viability and 
proliferation was studied 
using differentiated 
osteoblast cells. 
The authors were able to differentiate human 
endometrial stem cells in osteoblasts 
successfully. The diffusion of the nanofillers in 
the gel matrix was successful. In the cultures 
cell test, the scaffold proved not to be 
cytotoxic, but cells did not proliferate. 
Ghorbanian 
et al.96 




nanocomposites weight ratios 
were mixed, ultrasonicated and 
freeze-dried. A pure polymer 









The scaffolds were 
characterized, it pores 




were assessed as well. 
Finally, an in vitro 
evaluation of its 
cytotoxicity was 
performed for 1, 3 and 7 
days of culture. 
The produced scaffolds possess 
interconnected pores and almost sufficient 
porosity (70%) to provide good conditions for 
cell proliferation. Higher levels of diopside, 
decrease the amount of pores but improve the 
mechanical behavior. Moreover, adding 
diopside improves the hydrophilicity of the 
scaffold. The biocompatibility of the scaffold is 
excellent. 
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Table 6 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 
applications in the maxillofacial context (continued) 
 





of the cell 
Method of in vitro 
evaluation 
Outcome 
Liu et al.112 
Nanofibrous 
Gelatin 




A 3D nanofibrous gelatin scaffold 
was produced by thermally 
induced phase separation and 
leaching techniques. nHa was 








Mechanical tests were 
performed in the scaffold 
with and without the nano-
apatite component. Cells 
were seeded in both 
scaffolds to verify its 
biocompatibility and analyze 
the differences in their 
behavior. 
The biomimetic scaffold (mimicking 
chemical and physical architecture of 
natural bone ECM) proved to have 
good porous interconnectivity. Its 
biological and mechanical 
characteristics were proven to be 
excellent. The addition of apatite 
enhanced osteoblastic cell 
differentiation as well as mechanical 






A biomimetic 5 wt% SR/nHA 
nanocomposite was obtained 
through a uniform dispersion of 









The structural morphology, 
dispersibility of nHA into SR 
and mechanical properties 
were studied. 
Cytocompatibility and cell 
viability were assayed. 
Cellular test were performed 
in SR constructs and in SR-
nHA constructs during 14 
days and the cellular 
response was analysed. 
When nHA is added to the SR 
structure and a good dispersion is 
obtained, the biological response is 
favorable, including  cell attachment, 
higher viability and proliferation, and 








Two scaffolds were prepared: 
first nHA was deposited on the 
surface of electrospun PCG 
fibers via alternate soaking 
process and the second had HA 







Both scaffolds were 
compared regarding their 
microstructure, through 
characterization techniques. 
Physical, chemical and 
biological properties were 
assayed as well.  Biological 
properties such as cell 
proliferation, cell attachment 
were determined by growing 
the chosen cells over the 
scaffolds. 
The alternate soaking process 
demonstrated to provide better 
mechanical strength,   biocompatibility 
properties, since it allowed surface 
precipitation of nHA over the scaffold.  
The proliferation and cellular adhesion 
were also observed better on the 
scaffold that had nHA deposited on the 
already electrospun polymer. A good 
osteoestimulation capacity was also 
found. 
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Table 6 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 
applications in the maxillofacial context (continued) 
 
Ref. Polymeric Matrix Nano – filler 
Nanocomposite 
specifications 
Type of cell 
used 
Specifications 
of the cell 












The materials of PP/nHA and 
PP/MWNT/nHA 
nanocomposites were placed 
together by a melt-blending 








Structure and morphology of 
the scaffolds was analyzed. 
Thermal and mechanical 
assays were performed for 
characterization. In vitro 
cytocompatibility was tested by 
culturing the nanocomposites 
in a cell suspension at 37 °C 
for 24 and 72 hours. All the 
assays were done in samples 
with and without MWNT and in 
different amounts. 
Mechanical and thermal properties 
are improved by adding a low 
loadings of MWNT with nHA in a 
PP matrix. Regarding the cell 
culture, it was found that in 
samples with 0,3% MWNT-20% 
nHA, cells adhere and proliferate  
better than in samples without 
MWNT. 





Materials were synthetized to 
produce a 5 and a 10 wt% 





obtained from a 
2-month-old New 
Zealand rabbit. 
Characterization of the films 
was performed. Mechanical 
properties were assessed and 
in vitro cytocompatibility was 
evaluated in a 9 day assay. 
nHA integrates well in a NCECS 
matrix, producing an uniform film. 
Cell adhesion, growth and 
morphology are higher in the film 
that has a bigger nHA 
concentration (10 wt%), suggesting 
that the viability increases with the 











lactide) (HA-g PLLA) 
nanoparticles and poly (L-
lactide-co-glycolide) (PLGA) 
scaffolds were prepared by 
electrosppining at a 
concentration of 0, 5, 10 and 
20 wt%.A HA/PLA membrane 








Chemical and physical 
characterization of the 
electrospun fiber membranes 
was performed, as well as its 
in vitro degradation rate. The 
bioactivity was assessed by 
evaluating their ability to form 
apatite on their surfaces in 
simulated body fluid (SBF). 
The cell adhesion test was 
performed for a period of 12, 
24 and 48 hours. 
nHa-g-PLLA fibrous membranes 
exhibited better mechanics 
properties than control pristine 
PLGA and corresponding HA/PLA 
fiber membranes, which indicates 
that the grafting technique used to 
produce the nHA-PLLA membrane 
enhances its properties. The cells 
adhere well to the membrane, 
spreading and proliferation though 
time. 
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Table 6 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 
applications in the maxillofacial context (continued) 
 
 





of the cell 





Chitosan Silica xerogel 
70/30 wt% Chitosan-Silica 
xerogel hybrid membranes were 
fabricated through a sol-gel 
technique, followed by freeze 
drying.  Pure chitosan 









The membranes were 
characterized, their 
mechanical properties were 
assayed as well as its 
biodegradation rate and 
mineralization properties. 
The in vitro cell responses 




after a 10 day culturing. 
It was proven that the sol-gel process 
provides a highly efficient way of producing 
this scaffolds with a porous and uniform 
structure. The incorporation of the silica 
xerogel stimulated the production of a layer 
of apatite on the scaffolds surface, when 
immerged in SBF and affected the cells 
viability positively. Results show that the 








Ha/ PCL nanocomposite scaffold 
(40/ 60 wt %) prepared though a 









characterization of the 
scaffolds was performed. 
Cytocompatibility was 
assessed by a 15 day cell 
culture. The cells structure 
and biological behavior was 
analyzed and 
characterized. 
The method of preparation allowed highly 
porous scaffolds. Morphological analysis of 
the composite confirmed that the HA 
particles were distributed homogeneously 
within the PCL matrix. 
Biologically, cells spread and attached well 
to the scaffold’s porous structure and the 
mesenchymal cells differentiated into 







A high-strength injectable 











Mechanical tests were 
performed. The proliferation 
and osteogenic 
differentiation of the cells 
on high-strength CPC-
chitosan was investigated. 
By adding chitosan to CPC, it was possible 
to strengthen it and enhance its mechanical 
properties. The MSCs growth on the 
scaffold was evident and increased by an 
order of magnitude from day 1 to day 14. 
MSCs differentiated down the osteogenic 
lineage and proliferated considerably. 
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Table 6 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 











of the cell 









PHB/nHA scaffolds were 
produced using organic solvents 






cell line -  MG-
63 osteoblast 
The scaffolds were 
characterized, the porosity 
was measured, and 
mechanical tests like 
compression were 
performed. The 
biocompatibility in vitro was 
assessed by cell culture. 
After characterization, it was concluded that 
this scaffolds have an interconnected 
porous architecture with rather high porosity 
and that this characteristic is not affected by 
the amount of nHA. The dispersion of the 
HA nanocristals is affected by its amount: 
above a concentration of 15 wt%, 
agglomeration would occur, not allowing a 
good dispersion of the nanofiller. It was 
demonstrated that the scaffolds were 
biocompatible, though the observation of an 
appropriated cell-scaffold interaction 
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Table 3 – Results obtained regarding the in vitro studies of nanocomposites to be used in bone 





Nano – filler  Nanocomposite  
specifications 








20/80 wt% nHA/PCL scaffolds were 
prepared though 2 stages: an in situ 






The dispersion of the nHA on the 
PCL matrix was analyzed. The 
mechanical behavior of the 
scaffolds was compared to the 
characteristics of a pure PCL 
scaffold. The scaffold 
biocompatibility was evaluated by 
exposing it to SBF. 
The characterization of the scaffold revealed 
that the nano-ceramic particles were 
homogenously dispersed in the polymeric 
matrix. The adding of nHA improved the 
mechanical behavior of the scaffold. By 
exposing it to SBF, the scaffolds proved to 
have an excellent ability to precipitate bone 









PCL solutions with different 
percentages of nanoparticules and 
simvastatin drug were 




The fibers morphology and 
mechanical characterization was 
assed, as well as degradation 
measurements and in vitro drug 
releases studies. The in vitro 
bioactivity evaluation was carried 
out in SBF. 
The amount of nanoparticles added in the 
spinning solution, influenced the viscosity of 
the solution and the ability of spinning it. 
Moreover, the presence of nBG increased 
the mechanical properties and affected the 
nanofiber degradation and simvastatin 
release. The nanofibers showed excellent 
bioactivity, inducing the precipitation of bone 
like apatite mineral, when exposed to SBF. 
Lee et al.110 Chitosan Silica xerogel 
70/30 wt% Chitosan-Silica xerogel 
hybrid membranes were fabricated 
through a sol-gel technique, followed 
by freeze drying.  Pure chitosan 





The membranes were immersed 
in the SBF solution and 
incubated for 14 days to observe 
their mineralization. 
A membrane of pure chitosan 
was subjected to the same 
procedure for comparison 
puroposes. 
It was proven that the sol-gel process 
provides a highly efficient way of producing 
this scaffolds with a porous and uniform 
structure. 
After 1 days, apatite particles were visualized 
in the hybrid membrane. After 7 days, the 
surface was almost completely covered with 
a thin layer of apatite. The density of this 
layer increased until the 14th day, 
The chitosan membrane did not show any 
apatite particle after 14 days. 
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a) The choice of polymers   
 
In order to understand which polymers are used as matrixes in the in vitro 
studies considered for this review, an accounting was performed. It is important 
to refer that when a nanocomposite was composed by more than one polymer, 
they were accounted separately. Figure 17 represents the percentage of polymers 




It is possible to understand that a variety of different polymers was used as 
matrixes of the nanocomposites subjected to in vitro studies. Among them, 
polycaprolactone stands out with a percentage of 19% 88,89,97,98,101, followed by 
chitosan 100 that has a representation of 15%. Gelatin was used in 12% of the 
cases 94,103,108 and silk fibroin in 8%. All the others polymers have a 









































Polymers used as matrixes in the nanocomposites subjected to in vitro studies 
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b) The choice of nanofillers 
 
The nanofillers used in the in vitro studied nanocomposites were considered 
for accounting to understand which ones were requested the most. Figure 18 
demonstrates the accounting performed.  
 
 
Nano-hydroxyapatite stands out as having a 71% representation among the 
in vitro investigated nanocomposites 87-90,95,97,99-104,108,111-113,115. Calcium 
phosphate follows with a 9% representation 94,114 and all the other nanofillers 
























































 Nanocomposites have clearly proved their value for bone replacement, 
augmentation and regeneration.23,57,77,85 However, the variety of materials that 
can be combined and its properties and specifications is vast. Therefore, to 
understand which material combinations provide the best biological, structural 
and mechanical response is highly important. Polymer-ceramic nanocomposite 
systems are particularly interesting as they can be closer to bone in terms of its 
constitution which is mostly an intricate combination of two phases at the nano- 
level: hydroxyapatite and collagen. The present dissertation has as its main goal 
to analyze the most recent reported studies based on polymer-ceramic 
nanocomposites produced for bone replacement and regeneration, focusing on 
those that are suitable for craniomaxillofacial bone applications. This particular 
area has been in the forefront of biomedical technology as compared with the 
orthopedic field due to the less interventional nature of its applications as 
compared for instance with the orthopedic field.  
 
Materials Selection  
 
In Tables 4, 5 and 6, it is possible to identify all the constituting materials of 
the nanocomposites studied in the selected articles. Moreover, Figures 11, 15 and 
17 analyze the polymers used generally, in in vivo and in in vitro cases, 
respectively, while Figures 12, 15 and 18 make the same evaluation, regarding the 
nanofiller constitution.     
 
a) The choice of polymers   
 
Regarding their origin, polymers can be synthetic or derive from natural 
sources. As reported in Figure 11 of the results section, the majority of polymers 
contained in the articles analyzed in this review are from synthetic origin.  
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Polyamide, the most used polymer in the in vivo assays (Figure 15), has 
excellent mechanical and corrosion-resisting properties, resulting from the strong 
hydrogen bonds between its own macromolecules and its high affinity to form 
hydrogen bonds with nano-sized apatites116,117. Moreover, it presents a good 
biocompatibility since it reassembles in some extent the collagen protein both in 
chemical structure and active groups. Zhang et al.., in his published articles91-93 
used polyamide as the polymeric matrix component. In one of his studies,92 he 
blended polyamide with nHA, nAg and TiO2, producing a successful antibacterial 
scaffold.  In other two, he joined polyamide just with nHA and evaluated its in vivo 
performance on rabbits93 and rats91 In this last study, he used a polyamide with 
an aliphatic conformation (Polyamide 66). Li et al.34 produced a nHA/Polyamide 
scaffold as well and evaluated the same parameters. All these works 
demonstrated that this material provides great mechanical behavior allied to great 
biocompatibility.   
Polycaprolactone, the most used polymer in in vitro assays (Figure 17), is a 
biodegradable synthetic polymer that possesses a slow degradation rate. It 
belongs to a group of synthetic polymers with an amazing characteristic: by fine 
controlling their chemical synthesis and processing, mechanical and physical 
characteristics such as tensile strength, elastic modulus and degradation rate can 
be predicted and reproduced with precision. Polymers like poly(lactid acid) and 
poly(glycolic acid) belong to this group as well. Moreover, these polymers allow 
for creating scaffolds with different shapes according to the final outcome. These 
polymers however present a major drawback that is the inability to stimulate cell 
adhesion or bone growth (they are bioinert). By binding with nano-ceramic fillers, 
this drawback can be overcome. Raucci et al.88 were able to create a scaffold 
with excellent mechanical performance, while possessing bioactive 
characteristics capable of stimulating osteoblast differentiation from human 
mesenchymal cells, though homogeneous distribution of HA nanoparticles in the 
polycaprolactone matrix,.  Wang et al.,89 used a nanocomposite with the same 
composition, obtaining similar results, namely the osteoblastic differentiation but, 
this time, using bone marrow stromal cells extracted from dogs. A study by 
Jaiswal et al.,97 differed from the previous two by using gelatin in combination 
with polycaprolactone as a polymeric matrix, in order to produce an electrospun 
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fibrous polymeric scaffolds that were posteriorly coated with nHA though 
alternate soaked and blending techniques. When compared, alternate soaked 
nanocomposites proved to have better mechanical properties and to stimulate 
bone-like cells to proliferate more efficiently than blended scaffolds.   
Polypropylene, used by Liao et al.99 in their research, displays excellent 
chemical resistance, good stress crack resistance and flexibility. It has been 
proved that when implanted in tissue, this polymer retains its tensile strength over 
a large period of time118. However, polypropylene is bioinert. Besides the good 
properties of the polymer, the nanofillers used by Liao et al. are HA nanorods and 
carbon nanotubes (known for having an exquisite mechanical behavior). This 
combination provides a great mechanical behavior and superior dimensional 
stability. On the other hand, the incorporation of HA attributes the necessary 
bioactive characteristics. The in vitro outcomes corroborate these facts entirely.  
Chitosan, a natural biodegradable polymer, has a unique characteristic that 
highlights it from others: it possesses an innate anti-bacterial capacity. 
Additionally, it is flexible and can be transformed into fibers,100 membranes,110 3D 
scaffolds or injectable materials.114 However, reports119 have been published 
stating that chitosan’s bioactivity and righty are not satisfactory, particularly in the 
wet state. This same authors state that this disadvantages of chitosan can be 
resolved by adding reinforcement agents. In the present dissertation, four 
studies87,100,110,114  included a report choosing chitosan as a polymer matrix. By 
adding nHa, silica xerogel and calcium phosphate cement, Liu et al.,100 Lee et 
al.110 and Moreau et al.114 were able to achieve an excellent outcome regarding 
chitosan’s in vitro and in vivo performance, fact that corroborates Ignatius et al. 
119 theory, that states that the addition of bioactive ceramics to chitosan-based 
polymeric matrixes improves biocompatibility and osteoconductivity of this 
resorbable nanocomposites. Lu et al. 87 used an amphiphilic chitosan derivative, 
N-carboxyethylchitosan, because it already proved to be  more water-soluble and 
to have higher cell compatibility then chitosan. Unfortunately, for testing the in 
vitro cytocompatibility assey, he used different cells from other authors (rabbit 
tracheal cartilage cells), reason why it is not possible to clearly compare the 
results. More research should be conducted in this area.  
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The natural hydrophilic polysaccharides pullulan and dextran constitute 
interesting polymers for bone regeneration. They have a biochemical structure 
that reassembles the extracellular matrix, providing excellent physical support for 
bone growth and a good biodegradability behavior. Pullulan is a non-
immunogenic polysaccharide produced by a fungus, Aureobasidium pullulans 
and has great mechanical properties and biocompatibility95. Dextran was first 
used as a blood replacement constituent and is synthesized from sugar by 
bacteria. Together they form an easy-to-shape material with good mechanical 
properties, totally suitable for bone regeneration. In his study, Fricain et al.95 
tested a nanocomposite with nHa dispersed in this combination of 
polysaccharides in vitro, by using human bone marrow stromal cells and in vivo, 
in small (rats) and big animals (goats). These results show that nHa/Pullulan-
Dextran nanocomposites stimulate bone formation in vitro and in vivo in a short 
period of time.  
 
b) The choice of nano-fillers 
 
As referred in Figures 12, 15 and 18, nano-hydroxyapatite is the most used 
ceramic nano-filler in nanocomposites that were subjected to both in vivo and in 
vitro assays. The other relevant nanofillers are nano-apatite,109 silica xerogel,110 
calcium phosphate cement (CPC),94,114 bioactive glass (BG) nanoparticule 98 and 
diopside nanocristals.96 
Synthetic hydroxyapatite is a calcium-containing biomaterial composed of 
chemical elements similar to the ones present in natural bone. Due to its excellent 
biocompatibility, cell affinity, and osteoconductivity, HA stands out as being ideal 
for bone grafting. Conventional synthetic HA (microparticulated) however,  has a 
large particle size compared with natural bone HA and poor mechanical 
properties.120 Moreover, the microparticulated form debonds easily from the 
matrix, resulting in an inefficient stress-transfer mechanism in the matrix-filler 
interface. Nano-hydroxyapatite rises than as a solution for bringing the 
advantages of HA, while granting better mechanical properties in terms of 
strength, stiffness, toughness and fatigue resistance and being better retained 
within the polymeric matrix. In addition, nHA resembles more closely to bone 
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environment and enhances the cellular activity towards bone formation as 
compared to HA blend scaffolds. 
There are two major methods for hydroxyapatite synthesis: sintering (high 
temperature) and precipitation (lower temperature). The structural and chemical 
vary according to the production method. In fact, hydroxyapatite obtained through 
the first synthesis method, requires a high temperature sintering (1,250 °C), 
leading to a higher chemical stability and lower surface activity. This is probably 
why the majority of authors referred in this dissertation that use nHA, obtain it 
through the precipitation method.87,95,104,106,107,111.  
By introducing nHA on their surface, polymeric scaffolds become bioactive 
and osteoconductive. Therefore, it is considered that nHA functionalizes these 
scaffolds.  Among this review, HA functionalized scaffolds, have shown a great 
capacity to stimulate attachment and proliferation of osteoblasts94,97,99,115 or 
osteoblast like cells96,100,102,103,111-113 and to facilitate the differentiation of 
mesenchymal stem cells towards osteoblastic lineage88-90,95,100,108,109,114. Other 
interesting fact is that in some studies, the original hydroxyapatite stoichiometry 
was changed. Liu et al.112 used a partially carbonated HA in his assay, to mimic 
bone HA and produce a biomimetic nanofibrous-gelatin/nanoapatite as similar as 
possible to extracellular matrix. Li et at.104 in the other hand, produced a silver ion 
substituted nano-hydroxyapatite, due to the known antimicrobial activity of silver 
ions or silver-based compounds. Nano-hydroxyapatite can provide a large 
reservoir of silver ions, which can be released gradually resulting in long-term 
antimicrobial activity. Finally, Liao et al.99 have fabricated hydroxyapatite in form 
of nanorods incorporating carbon nanotubes to construct a nanocomposite with 
excellent mechanical properties which would be impossible to be reached with 
the pure HA crystalline form. Zhao et al.109, have grown apatite nanoparticles on 
the surface of a silk fibroin-polyaspartic acid scaffold though an alternate soaking 
process. Moreover, these mineralized scaffolds were seeded with bone marrow 
stromal cells (bMSC) and implanted in dog’s mandibles. In vivo, they 
demonstrated bioactivity, showing a bone mineral density very similar to the host 
bone. When compared to the same seeded scaffolds, without the nanoapatite 
particles, the first ones show a better in vivo outcome. Both the osteoconductive 
and osteophilic characteristics are then demonstrated in this study.  
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Silica xerogel was used by Lee et al.110 as the inorganic constituent of the 
scaffold. It consists in solid nanoparticles formed from a silicate gel by drying with 
unhindered shrinkage. This material has demonstrated great promise for the 
biomedical field, since its composition can be turned so they can express, in this 
specific case, bioactive glasses characteristics. Moreover, low temperature 
processing enables them to carry biologically active agents useful for drug 
delivery, for example. Lee et al.110 used this silica xerogel as the nanofiller of a 
homogeneous chitosan-silica xerogel hybrid nanocomposite. This 
nanocomposite proved to have excellent mechanical characteristics, great 
apatite forming ability as well as good cellular responses. Moreover, it promoted 
in vivo bone regeneration on rat calvarium bone defects. 
Calcium phosphate cements have been attracting great attention due to 
their excellent biological behavior (e.g. biocompatibility, bioactivity and 
osteoconductivity). Nowadays, CPCs can be found commercially such as 
Eurobone® (Kasios®) or Calcibon® (Biomet®). In addition to their excellent 
biological behavior, the main advantages of CPCs are that they are presented in 
a particulated form and can be injected having the ability to harden in vivo at body 
temperature (in situ).121 However, CPCs have major drawbacks: i) without any 
additives, they have poor injectability properties due to the liquid – solid phase 
separation, ii) CPC pastes tend to disintegrate upon early contact with blood or 
biological fluids due to their weak cohesion and finally and most important, iii) 
CPCs have very poor mechanical properties, not only in terms of strength, but in 
terms of toughness, brittleness and reliability.122 Monreau et al.114 created a 
chitosan/CPC injectable scaffold and tested the biological behavior of 
mesenchymal stem cell harvested from Wistar Hannover male rats. Firstly, he 
concluded that the adding of chitosan to the scaffold enhanced the mechanical 
properties of the CPC/chitosan nanocomposite. In addition, mesenchymal cells 
responded to the bioactivity of the CPC, adhering, differentiating and proliferating 
throughout the scaffold. Azami et al.94 performed a similar study using a 
gel/amorphous calcium phosphate scaffold and assessing the biological behavior 
of human endometrial stem cells, namely if they differentiate to osteoblast cells.  
He concluded that human endometrial stem cells were successfully differentiated 
to osteoblast like-cells by the osteogenic media offered by the produced scaffold.  
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 Bioactive glasses are composed by calcium and phosphate which are 
present in a proportion similar to the bone hydroxyapatite. These glasses have 
an excellent biocompatibility and a great ability to form surface apatite, bonding 
to bone. Kouhi et al.98 used these materials as a nanofiller for a poly(ε-
caprolactone) matrix. Though electrospinning, increased crystallinity nanofibers 
were produced and its biological behavior was accessed as well as the drug 
delivery of Simvastatin. The nanocomposite nanofibrous web demonstrated 
excellent bioactivity, inducing the precipitation of bone like apatite mineral on its 
surface under a simulated physiological medium. The nanocomposite 
nanofibrous web demonstrated excellent bioactivity, inducing the precipitation of 
bone like apatite mineral on its surface and the bioactive particles allow the 
controlled drug release of simvastatin throughout time.  
 Diopside (CaMgSi2O6) is a mineral that has been reported as a feasible 
biomaterial as a bone substitute since it demonstrated to possess more potential 
of apatite formation ability and higher mechanical strength than hydroxyapatite 
itself.123 Ghorbanian et al.96 produced a 3D porous scaffold by combining 
diopside nanocrystals with silk fibroin through a freeze-drying process. This 
combination turned out to provide better mechanical characteristics than the SF 
scaffolds alone. In addition, diopside increased the wettability of the scaffold, 
enhancing the cell migration towards the scaffold. The fact of having such good 
mechanical properties, makes this type of scaffolds an excellent resource for 
maxillofacial bone regeneration.  
 
In vivo Assays 
  
Biocompatibility is often used incorrectly with in vitro tests. In fact, 
biocompatibility can only be used in the case of animal or humans (in vivo tests), 
with the correct term being cytocompatibility for in vitro tests.124  
Animal models are considered to be an essential step in the testing of 
orthopedic strategies, prior to clinical use in humans. When selecting the animal 
model, some factors should be taken under consideration: ability to observe 
numerous subject over a relatively short time frame, availability, cost to acquire 
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and care for animals, acceptability to society, lifespan suitable for the duration of 
the study, tolerance to captivity and ease of housing, low maintenance care, ease 
of handling, resistance to infection and disease, inter-animal uniformity, biological 
characteristics analogous to humans, tolerance to surgery, adequate facilities 
and support staff and an existing database of biological information for the 
species.124 Specifically for study of bone regeneration materials, an 
understanding of the species specific bone characteristics such as bone 
microstructure and composition, as well as their bone modeling and remodeling 
properties is needed and these features should be as similar to human bone as 
possible. According to Pearce et al.124, the most important characteristics that 
should be compared between human’s bone and the animal model’s bone are: 
Macrostructure, microstructure, bone composition and bone remodeling. The 
similarity between human and the most used animal model bone is compared in 
table 7.  
 
Table 7- Summary of the four attributes in terms of similarity between animal 
and human bone 124 
 
 
No species fulfills all the requirements of an ideal model, since each animal 
model has its unique advantages and disadvantages, regarding mechanical and 
physiological approximation of human bone. International standards established 
that the species suitable for testing implementation of materials in bone are dogs, 
sheeps, goats, pigs or rabbits.  
Among the in vivo referenced studies, rats stand out as being the most used 
animal (Figure 13), in both biocompatibility evaluation through non-osseous 
 Canine Goat Pig Rabbit Rat 
Macrostructure ++ +++ ++ + + 
Microstructure ++ + ++ + + 
Bone composition +++ ++ +++ ++ + 
Bone remodeling ++ ++ +++ + + 
Legenda: + least similar, ++ moderately similar, +++ most similar 
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implantation and osseous implantation. The use of rodents (rats and mice) is 
popular among research groups due to the fact that they are inexpensive, easy 
to house, have high availability and have a satisfactory immune system.125 
Therefore, these animals qualify for a starting point of the in vivo performance 
analysis of a bone regeneration material, which means their biocompatibility 
assessment through non-osseous implantation. Some authors92,95, 106 reported in 
this review used this strategy. However, rodent’s bone has a very significant 
dissimilarity to the humans bone at many levels. As a result, the regeneration 
outcomes of implanting biomaterials in rats bone can hardly be used to predict 
the materials behavior in humans.124  
Rabbits are reported to be one of the most used animal models in medical 
research.124 As rats, they have a major drawback related to its size that makes it 
not suitable for the assessment of multiple implant materials in the same model. 
In fact, international standards state that the maximum amount of implanted 
materials in rabbits is 6, which is half the maximum number of implants 
recommended for bigger sized animal models such as dogs or goats.  Moreover, 
rabbits bone structure continues to be very different from human bone. Despite 
all this disadvantages, rabbits have a convenient bone maturity rate of 6 months 
after birth and a faster skeletal change and bone turnover. This allows faster 
results in the in vivo assays, but at the same time, moves further from the 
similarity to humans bone remodeling mechanisms.  Zhang et al.93, in their study, 
used rabbit mandibles to understand if the biomimetic nHA/polyamide scaffold 
that they produced was suitable for maxillofacial bone regeneration. The outcome 
of the assay is a complete regeneration of the created bone defects and based 
on it, the authors refer that this material has an interesting potential for 
maxillofacial reconstructive procedures in load-free areas, but further studies are 
warranted. Other referred authors105,106 that recurred this animal models have a 
similar position, stating that they should be followed by larger animal models 
testing.  
Goats arise as animal models that have a body size suitable for the 
implantation of multiple implants per goat. Moreover, and even though the 
composition of goat’s bone does not match entirely human bone, goats have a 
metabolic and bone remodeling rate very similar to that of humans. However, the 
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rate at which a bone graft is vascularized and converted into vital bone structure 
is faster in goats, occurring at approximately 3 months, in comparison to 8 months 
in humans. Only one of the reported articles, Fricain et al.,95 used goats in his 
study. In fact, by using two different animals (mice and goat), the authors ensured 
the great potential of the created pullulan/dextran/nHA nanocomposite, since the 
change of environment did not compromise the successful regeneration final 
outcome.  
In terms of bone composition and density, dogs and pigs are the animal 
models that most closely represent the human anatomy and phisiology. However, 
and even though pigs demonstrate a great likeness with human bone, difficulties 
may arise in relation to their increasing size with time, which makes it an 
inconvenient animal model.95 In terms of composition, water fraction, organic 
fraction, volatile inorganic fraction and ash fraction of dog and human’s bone are 
reported to be extremely similar.126 Moreover, the load bearing capacities of 
human’s bone is comparable with dog’s bone, especially in the maxillofacial area, 
even though bone loading in dogs is bigger. Zhao et al.109 choose to evaluate the 
maxillofacial regenerative capacity of an apatite-coated silk fibroin scaffold in dog 
mandibles, combining the scaffold with mesenchymal stem cells extracted from 
the same animal. As a result, he obtained excellent mineralization of the canine 
inferior mandibular border defects, the scaffold was able to bear the high bone 
loading of that specific site and the author successfully proved that this 
nanocomposite strategy is suitable for maxillofacial applications.  
  
81 
In vitro Assays 
  
 
a) Characterization and properties of the nanocomposites 
 
 Nanocomposite scaffolds, in order to be considered as part of a valid bone 
regeneration strategy, have to be cytocompatible. Another essential property of 
cytocompatible scaffolds is its surface properties and surface to bulk ratio, which 
increases with increasing porosity80 or decreasing size in particulate systems.65 
Depending on the specific application it is possible to find nanocomposites in 
different forms. For instances, Zhang et al.93 developed a porous 
hydroxyapatite/polyamide nanocomposite to implant in mandibular critical size 
defects, while Fu et al. 106 created an injectable nanocomposite with a 
poly(ethylene glycol)-poly(ε-caprolactone)-poly(ethylene glycol) (PEG-PCL-
PEG) copolymer and collagen matrix filled with nano-hydroxyapatite particles for 
bone injection in a minimally invasive manner. When considering applications 
where a considerable extension of bone needs to be regenerated porous 
scaffolds are preferred to particulate systems due to its superior mechanical 
stability. A porous scaffold can provide an ideal physical structure for bone cells 
to infiltrate the scaffold and to produce new bone. Additionally, it contributes for 
implant stability by biological fixation.93 A porous structure can be induced as a 
consequence of the processing method. Processing methods that induce porosity 
can use temperature as in the phase inversion process reported by Li et al.34 and 
Liu et al.112 or can evaporate a component, as reported by Li et al.104,107 Freeze-
drying (also called lyophilization or solvent sublimation), is another technique 
used to induce porosity that results from freezing a solution and then allowing the 
frozen water in the material to sublimate by reducing the pressure as reported in 
this review.87,94-96,103,106,108,110,111 Inducing porosity by a chemical way is also 
possible, by using a chemically induced phase inversion, as Raucci et al.88 
described or by using organic solvents, as presented by Nemati et al.115  
 Particle leaching is another technique that has been used to induce 
porosity. It consists in using a porogen (which can be constituted by different 
materials that typically must have a high dissolution capacity) dispersed in the 
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material’s bulk and removing it by a leaching technique. Once the porogen is 
dissolved, a porous structure is formed. Raucci el al.88 and Wang et al.89 have 
used this technique with sodium chloride particles, which are leached out after 
immersion in water (the so-called salt-leaching technique) .  Liu et al.112 used 
paraffin in a matrix of gelatin that was further soaked in hexane to leach out 
paraffin spheres. One of the advantages of this technique is that the porosity can 
be easily controlled by the size and shape of the sacrifice porogen. 
Processing methods such as electrospinning, create a material constituted 
by randomly disposed fibers, generating a subsequent porous structure. Several 
authors90,97,98,100,102 have used electrospinning to produce porous scaffolds. 
However, significant challenges still exist in using this technique to fabricate 
complex 3D scaffolds shapes or to generate designed internal pore structure, 
limiting its potential for many tissue engineering applications.80 
The size, number of pores and its interconnectivity are as important as their 
existence. It was reported127,128 that a satisfactory porosity level is achieved for 
percentages of more than 80% and that the ideal pore size is between 200 and 
400 µm.129,130 Moreover, the interconnectivity of pores together with the pore size 
can modulate cellular ingrowth in the scaffold.130,131 Pores of less than 10 µm 
inhibit cellular in-growth, while pores between 15 and 50 µm help fibrovascular 
colonization. Pores between 50 and 150 µm determine osteoid growth and pores 
higher than 150 µm facilitate internal mineralized bone formation.131 From the 30 
selected articles, only 8 specified the percentage of porosity existing in the 
nanocomposite and 13 specified the pore size. Among these, Liu et al.112 and 
Tan et al.108 were able to create the highest pore percentages, with 97,5 % and 
97,9%, for a gelatin/apatite nanocomposite and a calcium alginate hydrogel as 
matrix to carry nHA and collagen particles, respectively. In fact, Tan et al.108 was 
able to establish a direct relationship between the concentration of calcium 
alginate in the nanocomposite and the pore percentage – as the alginate 
concentration increases, porosity decreases – achieving high porosity level with 
a 2% alginate concentration. Other authors achieved lower amounts of porosity 
such as 65 - 70%93, 70%96, 72% ± 4%34, 82%94 and 88,5%107. Regarding pore 
size, almost all articles that mentioned this value are included among the 
considered ideal gap from 200 µm to 400 µm. However, if in one hand porosity 
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enhances the biological capacities, in the other, it decreases the 
nanocomposite’s mechanical properties, making the structure too brittle and 
fragile.103 The work of Tan et al.108 constitutes a good example of this, reporting 
that the nanocomposite that he created and evaluated has excellent biological 
response in vivo, but does not fulfill the mechanical requirements for being 
implanted in a load bearing site.    
Other very important property of a nanocomposite surface is hydrophilicity. 
In fact, a certain affinity to water can help to immobilize growth factors and diffuse 
nutrients in bone native tissues and scaffolds, enhancing the adhesion of host 
cells. To support this theory,  Fuard et al.132 proved that the addition of a 
hydrophilic substrate (Poly-Di-Methyl-Siloxane) to a silicone polymer structure 
highly favors the cell adhesion. However, this authors were not able to establish 
the ideal value of hydrophilicity. In order to measure the hydrophilicity of a 
nanocomposite, water angles should be measured and analysed - the smaller 
water contact angles are, the best hydrophilicity is presented by the 
nanocomposite. Ghorbanian et al.,96 by measuring  the water contact angles in a 
diopside/silk fibroin  scaffold with and without the diopside nanoparticles, was 
able to conclude that, as the diopside content increased, the water contact angle 
decreased. This means that diopside nanoparticles conferred better 
hydrophilicity, which is this case has provided a better environment for cell 
attachment. 
 
b) Biodegradation and mechanical strength  
 
Since bone regeneration strategies are commonly intended to serve as 
temporary replacement for the extracellular matrix, they should present, besides 
excellent biocompatibility, suitable biodegradability and sufficient mechanical 
strength to ensure tissue functionality.106 In other words, the mechanical load 
should be supported initially by the scaffold and gradually transferred to the newly 
forming bone, according to the biodegradation profile of the composite.55 Within 
a nanocomposite, it can be ideally considered that the bioceramic filler will induce 
a bioactive behavior towards bone regeneration by self-degradation, so the space 
formed by that degradation can be replaced by new bone. On the other hand, the 
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polymer matrix would have to degrade slowly, to compensate the quick 
degradation of the nanofiller, so both materials end up giving space newly formed 
bone.   
 Among the retrieved published papers in the last 5 years several studies 
propose nanocomposites based on synthetic polymers and others on natural 
polymers. Polycaprolactone, is a very interesting polymer, because it offers two 
excellent degradation features: it degrades slowly in an in vivo environment, 
showing a good mechanical stability while the degradation process and its 
degradation products do not generate an acidic environment in the surroundings. 
Therefore, this polymer does not cause a major inflammatory reaction.97 These 
reasons can help to explain the fact that polycaprolactone is the most used 
polymer in the articles that constitute this review. 88,89,97,98,101  
Silk fibroin, due to its structural conformation, degrades considerably slowly 
as well and has relatively good mechanical properties. However, Kweon et al.105 
reports that during an in vivo study using a scaffold made of nano-hydroxyapatite 
implanted in rabbit’s parietal bony defects, an inflammatory reaction appeared 
which was attributed to degradation of the silk graft materials. In contrast, Zhao 
et al.109, used a silk-fibroin matrix in a in vivo assay in dog’s mandibles and did 
not report any inflammation episode.  
 Gels, hydrogels and other gelatin-based matrixes were the selected 
polymers for some of the analyzed nanocomposites94,100,103,106,108. This class of 
nanocomposites are considered very attractive because they have good 
biocompatibility, low immunogenicity, low cost, biodegradability, increased cell 
adhesion, migration, differentiation and proliferation. However, their very poor 
mechanical properties limit its application, especially for load bearing tissues or 
very big defects. The addition of nanomaterials as structural reinforcement is an 
interesting solution for this problem. Nanoparticles, because of the physical 
properties associated to their size, immediately work as reinforcement materials.  
Chiu et al.103 found that the addition of nHA was not enough for significantly 
improving the low mechanical properties of the gelatin matrix and proposed to 
reinforce it with TiO2 nanoparticles and a siloxane cross linker. Interestingly, the 
presence of these particles reduced the gelatin’s degradation rate. 
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 In order to access the biodegradation properties of the polymer-ceramic 
evaluated nanocomposites, some authors performed in vitro degradation assays. 
Thermal degradation tests87,103 and weight loss measurements after immersing 
the scaffolds in phosphate buffered saline89,98,102,110 or in fetal bovine serum90 are 
the most common methods to investigate the degradation kinetics of a scaffold.  
In order to evaluate the mechanical properties, the main performed tests 
were compressive tests to measure the compressive strength and respective 
modulus. The elastic modulus was measured in some studies as well. It is 
important to refer that the aim of any biomaterial used for bone regeneration is to 
match the mechanical properties of native bone. Zhang et al. 93, for example, was 
able to produce a porous hydroxyapatite/polyamide nanocomposite that 
possessed a compressive strength of 3-7 MPa, which is similar to living 
cancellous bone (2-15 MPa), 93 being therefore considered to be a good 
candidate for in vivo applications. Additionally, Azami et al.94 was able to 
determine that the elastic modulus of a biomimetic nanocomposite scaffold based 
on a GEL/calcium phosphate constitution is 80 ± 5 MPa. This value is comprised 
in the known elastic modulus of spongy bone (20-500 MPa).  
 
c) In vitro bioactivity evaluation  
 
Bioactivity is defined as the capacity of a certain material to bond to natural 
body structures, like bone or soft tissues. In polymer-ceramic nanocomposites, 
the bioactivity is related with the nano-bioceramic used in its composition. 
Therefore, the nanocomposite’s bioactivity can be defined as the ability of the 
ceramic component to establish a chemical bond with the host bone tissue. This 
includes enhancing the ability of apatite formation, osteoblast differentiation and 
bone matrix formation.133 Currently, two common methods have been used for 
testing the in vitro bioactivity. One method is to evaluate the apatite-formation 
ability of bioceramics in the simulated body fluid solutions (SBF). The other 
complementary method is to investigate the in vitro bone-related cell response to 
assayed materials. In this review, some of the in vitro studies have performed the 
SBF assay,98,101,110 while others have used biological assays using bone-related 
cells.87,94,96,97,99,102-104,110-113,115  
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 Bioactivity assessment using a SBF solutions was reported as being an 
effective way of reproducing the formation of bonelike apatite on the surface of 
the tested material.134 However, when this procedure is used, it is important to 
understand that the biochemistry of in vivo bone formation is different for each 
bioceramic. Silicate-based bioceramics, as silicate bioglasses or diopsides, bond 
to natural bone through the formation of bone like apatite layers due to the 
dissolution of Ca2+ or other metal ions, followed by the deposition of CaP in the 
surrounding tissue.133 In contrast, phosphate-based bioceramics such as HA or 
β-TCP, bond to natural bone directly.133 Therefore, nanocomposites that have in 
their constitution a silicate-based bioceramic, are more likely to produce apatite 
crystals on its surface when exposed to SBF then nanocomposites having 
phosphate-based bioceramics.133 It can be then considered that the bioactivity 
test using SBF alone would be better complemented by an in vitro cell study to 
confirm the results. In his article, Lee et al.110 uses both assays to evaluate the 
bioactive behavior of the hybrid chitosan-silica xerogel membrane, but Rezaei et 
al.101 on the other hand, finds the SBF assay sufficient to evaluate the bioactivity 
of a hydroxyapatite/polycaprolactone (HA/PCL) nanocomposite even though it is 
constituted by a silicate-based bioceramic.  
 At a cellular level, the nanocomposites were tested using two major cell 
types: (a) mesenchymal stem cells, which are multipotent stromal cells that have 
the capacity to differentiate in different kind of cells according to the external 
stimuli and (b) osteoblastic cell lines which are already differentiated bone-like 
cells with the ability to produce mineralized bone. The bioactivity of 
nanocomposites was then tested by evaluating if they had the capacity of 
stimulating mesenchymal cells to differentiate into an osteoblastic cell line88,114 or 
if they were able to promote osteoblasts adherence, proliferation and ECM 





Bone healing is a complex integrated process where there is temporal-
spatial interaction between various factors resulting in regeneration. During bone 
healing, the body itself generates a natural scaffold on which cells differentiate 
and under influence of various factors ultimately leads to timely regeneration of 
the lost tissues. Thus, an interesting approach to successful bone tissue 
regeneration is to provide the repair site with sufficient osteogenic progenitor cells 
in a suitable deliver vehicle to ensure osteoblastic differentiation and optimal 
secretory activity.135 Li et al.34 studied the effect of MSCs transfected with BMP-
7 implanted in an n-HA/PA scaffold. After an in vivo evaluation of the bone 
regeneration capacity of this assembly in rabbit mandibles, the authors concluded 
that MSCs accelerated the bone regeneration after implantation during the early 
stages.  
However, BMPs are unstable and high-doses therapies are costly. In order 
to find a solution for this disadvantage, Li et al.107 created P24, a novel short 
peptide obtained from peptides 73 to 92 of the knuckle epitope of BMP-2 and 
incorporated it in a nHA/collagen/poly(L-lactic acid) scaffold, using the 
biodegradable properties of the poly(L-lactic acid) to promote a controlled release 
of this novel peptide. After assessing the improved osteoinductivity of P24 in vitro, 
the authors implanted the same nanocomposite with P24 and with rhBMP2 in rats 
to assess if their bone regeneration capability. They were able to conclude that 
the incorporation of 3 mg of P24 in the nanocomposite resulted in a similar effect 
that identical nanocomposites filled with 1 mg of rhBMP-2.  
 
Antibacterial Agents Incorporation 
 
Nanocomposites implanted in vivo are often affected by bacterial 
colonization. If the aimed regenerating site is the alveolar bone, bacteria like 
Porphyromonas gingivalis, Streptococcus mutans and Fusobacterium 
nucleatum, which are the major pathogens of periodontitis and periimplantitis are 
likely to infect the nanocomposite and result in an inflammatory reaction and 
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subsequent failure of the bone regeneration procedure. Therefore, the 
incorporation of an antibacterial component can be an effective way to improve 
the nanocomposite functionality.  Silver ions (Ag+) in the composite membrane 
can inhibit the adhesion and proliferation of bacteria. It has been reported136 that 
Ag+ can cause bacterial inactivation by binding both to microbial DNA and to the 
sulfhydryl groups of the metabolic enzymes of the bacterial electron transport 
chain as well as by preventing bacterial replication. Two authors92,104 considered 
in this dissertation used Ag to accomplish an antibacterial effect of the 
nanocomposite. The first,95 used a composite slurry from silver ion-substituted 
nano-hydroxyapatite, titania nano-particles and polyamide 66 to create a novel 
antimicrobial membrane. The kinetics of the antibacterial release was positively 
assessed, since the selected biodegradable polymer provided the ideal 
conditions to a controlled release of the silver ions. Additionally, this 
nanocomposites provided a complete closure of 5-mm bone defects created in 
the skull of rats, without demonstrating any adverse reaction. The second, 97 used 
the exact same membrane, produced by the previous author,95 and studied its 
biosafety, biocompatibility and regeneration capacity, using an e-PTFE 
membrane as a positive control. By subcutaneous implantation, the 
nanocomposite in study proved to possess a great biocompatibility, showing no 
adverse reactions. By osseous implementation, it proved to have osteogenic 
activity comparable with conventional e-PTFE membranes, a material that has 
excellent osteogenic properties, but is non-resorbable, having the huge 
disadvantage of needing a second surgical procedure, as already referred 


























V. Conclusions and Future Perspectives 
 
Polymer-ceramic nanocomposites are innovative materials that due to their 
constitution can allow for mimicking the complex architecture of native bone 
tissue. The introduction of theise materials in the field of bone regeneration field 
is sustained by a good mechanical performance allied with great biocompatibility 
in vivo, leading to a successful outcome.  
In order to accomplish great performance, different types of polymers and 
ceramic nanofillers are joined together. Polymers can be natural or synthetic and 
biodegradable or non-biodegradable, and these characteristics determine 
whether they constitute a good candidate as a nanocomposite matrix or not. In 
fact, it was concluded that biodegradable polymers such as polycaprolactone are 
suitable for bone regeneration, since they are degraded in vivo though a specific 
degradation rate, providing space for new bone to grow and provide the 
regeneration of the implanted defect successfully. Moreover, synthetic polymers 
are proven to be better for integrating nanocomposites, since the can be modeled 
to have suitable properties, conferring in the end better mechanical and biological 
behavior. Natural-based polymers have been gaining more and more interest in 
the latest years mostly since they can better mimic the extracellular matrix of 
bone, can provide an adequate environment for establishing a chemical bond 
with the inorganic nanofiller and also because they are able to generate non-toxic 
products upon their degradation process. 
As far as nanofillers are concerned, nano-hydroxyapatite demonstrated to 
be the most studied and reliable option. Because it matches with the natural 
ceramic component of bone, its dispersion in the polymeric matrix ensures 
bonding to bone structure and stimulates native regeneration.  
A good dispersion of the nanoparticles in the polymeric matrix, provided by 
an effective incorporation technique is essential to ensure mechanical properties, 
since it avoids the creation of voids that provide conditions for cracking as well 
as of nanoceramic agglomerates that leads to the nanocomposite failure. 
Incorporation protocols such as melt blending, alternate soaking and high 
pressure solidification proved to be effective. 
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Porosity of the final regeneration scaffold is essential for providing physical 
structure for bone ingrowth. It can come as a result of the nanocomposite 
construction or it can be stimulated by specific procedures. Size and number of 
pores has to be taken in consideration as well.  
The addition of other components to nanocomposites, can enhance their 
features. Adding silver nanoparticles confers antibacterial properties to the 
scaffold and titanium particles apparently increase bone formation in vivo.  
Moreover, seeding stem cells from the host to the nanocomposite, increases its 
bioactivity. When implemented in the nanocomposite, stem cells receive specific 
stimuli and differentiate into bone-cells that have the ability to produce new bone. 
In the future, much more research is needed to understand the mechanism 
of nanocomposite–tissue interactions and to optimize the composition, structure 
and properties of different polymer-ceramic nanocomposites, in order to finally 
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Annex 1 – Research Diagram  
